{"id":"CHEMBL106","canonicalSmiles":"OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F","inchiKey":"RFHAOTPXVQNOHP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUCONAZOLE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Canesten oral","Diflucan","Diflucan In Sodium Chloride","Diflucan one","Fluconazole","Fluconazole In Sodium Chloride","Triflucan"],"synonyms":["BAYT-006267","BAYT006267","Diflucan","Fluconazole","UK-49,858","UK-49858"],"crossReferences":{"DailyMed":["fluconazole"],"PubChem":["144204972","144209438","144210898","170464782","174007447","26748877","26753743","49666152"],"Wikipedia":["Fluconazole"],"drugbank":["DB00196"],"chEBI":["46081"]},"childChemblIds":["CHEMBL1163001"],"count":32,"approvedIndications":["EFO_0007228","MONDO_0002026"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1990 and is indicated for candidiasis and cryptococcal meningitis and has 30 investigational indications."}
{"id":"CHEMBL1079","canonicalSmiles":"Clc1ccc2nsnc2c1NC1=NCCN1","inchiKey":"XFYDIVBRZNQMJC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIZANIDINE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Tizanidine","Zanaflex"],"crossReferences":{"DailyMed":["tizanidine%20hydrochloride"],"PubChem":["144205429","170465419","26754628","29216212","29216213","90340638"],"Wikipedia":["Tizanidine"],"drugbank":["DB00697"],"chEBI":["63629"]},"childChemblIds":["CHEMBL1200329"],"count":3,"linkedTargets":{"rows":["ENSG00000184160","ENSG00000274286","ENSG00000150594"],"count":3},"linkedDiseases":{"rows":["HP_0001257","EFO_0000756","MONDO_0002959","HP_0003419","HP_0006986","MONDO_0043510","EFO_0003843","HP_0000023"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 3 investigational indications."}
{"id":"CHEMBL1092067","canonicalSmiles":"OC[C@H]1O[C@H](O)[C@H]([18F])[C@@H](O)[C@@H]1O","inchiKey":"ZCXUVYAZINUVJD-AHXZWLDOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUDEOXYGLUCOSE F 18","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1086863","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fludeoxyglucose f18"],"synonyms":["18-FDG","18FDG","18f","Fludeoxyglucose (18f)","Fludeoxyglucose f 18","Fludeoxyglucose f(sup 18)","Fludeoxyglucose f-18","Fluorine f 18 fluorodeoxyglucose","Fluorodeoxyglucose f 18","S8FDG"],"crossReferences":{"DailyMed":["fludeoxyglucose%20f-18"],"chEBI":["31617"]},"count":31,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1994 and has 31 investigational indications."}
{"id":"CHEMBL113178","canonicalSmiles":"C[Se]CC[C@H](N)C(=O)O","inchiKey":"RJFAYQIBOAGBLC-BYPYZUCNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SELENOMETHIONINE","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Selenomethionine"],"crossReferences":{"PubChem":["144206245","50125779"],"drugbank":["DB11142"],"chEBI":["30021"]},"childChemblIds":["CHEMBL1201054"],"count":4,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1973 and has 4 investigational indications."}
{"id":"CHEMBL1135","canonicalSmiles":"CN(C)CCO","inchiKey":"UEEJHVSXFDXPFK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMETHYLAMINOETHANOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DMAE","Dimethylaminoethanol","N,N-Dimethylaminoethanol"],"crossReferences":{"PubChem":["144206714","144209019","144213161","29215350"],"Wikipedia":["Dimethylethanolamine"],"drugbank":["DB13352"],"chEBI":["271436"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL1163068","canonicalSmiles":"C[C@@H](O)[C@H](N)C(=O)NS(=O)(=O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O","inchiKey":"UPVAPSGKXAAHBG-CKTDUXNWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1163068","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03355"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1173","canonicalSmiles":"O=c1[nH]cc(I)c(=O)[nH]1","inchiKey":"KSNXJLQDQOIRIP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1173","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03554"],"chEBI":["43636"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL117785","canonicalSmiles":"COc1cc2c(cc1OC)C1CC(=O)C(CC(C)C)CN1CC2","inchiKey":"MKJIEFSOBYUXJB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TETRABENAZINE","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nitoman","Revocon","Tetmodis","Tetrabenazine","Xenazine","Xenazine 25"],"synonyms":["NSC-169886","RO 1-9569","RO-1-9569","RO-19569","Tetrabenazine"],"crossReferences":{"DailyMed":["deutetrabenazine","tetrabenazine"],"PubChem":["144205356","170464675","29216102","50086515","90341774"],"Wikipedia":["Tetrabenazine"],"drugbank":["DB04844"],"chEBI":["64028"]},"childChemblIds":["CHEMBL3137326"],"count":3,"approvedIndications":["Orphanet_399"],"linkedTargets":{"rows":["ENSG00000165646"],"count":1},"linkedDiseases":{"rows":["Orphanet_399","EFO_0004280","MONDO_0003441","EFO_0004895","EFO_1000632","EFO_0004152"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and is indicated for huntington disease and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1182714","canonicalSmiles":"CNCCCOc1cc(F)c(-c2c(Cl)nc3ncnn3c2N[C@@H](C)C(F)(F)F)c(F)c1","inchiKey":"ZUZPCOQWSYNWLU-VIFPVBQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEVIPABULIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cevipabulin"],"crossReferences":{"drugbank":["DB12533"]},"childChemblIds":["CHEMBL2107323","CHEMBL2107322","CHEMBL262314"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1200392","canonicalSmiles":"CN(C)CCOC(C)(c1ccccc1)c1ccccn1.O=C(O)CCC(=O)O","inchiKey":"KBAUFVUYFNWQFM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOXYLAMINE SUCCINATE","yearOfFirstApproval":1948,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1004","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Decapryn","Doxy-sleep-aid","Doxylamine succinate","Unisom"],"synonyms":["Doxylamine succinate","NSC-74772"],"crossReferences":{"DailyMed":["doxylamine%20succinate"],"PubChem":["144207064","144209276","144213178","170465171","26747491","50106112","56423151","855569"],"chEBI":["82461"]},"count":3,"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","EFO_0000544","HP_0002017"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1948 and has 3 investigational indications."}
{"id":"CHEMBL1200436","canonicalSmiles":"C[C@]12COC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O","inchiKey":"QSLJIVKCVHQPLV-PEMPUTJUSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"OXANDROLONE","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Anavar","Oxandrin","Oxandrolone"],"synonyms":["NSC-67068","Oxandrolone","Oxandrolone ciii","SC 11585","SC-11585"],"crossReferences":{"DailyMed":["oxandrolone"],"Wikipedia":["Oxandrolone"],"drugbank":["DB00621"],"chEBI":["7820"]},"count":8,"linkedTargets":{"rows":["ENSG00000169083"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0007312","Orphanet_84","EFO_0005938","EFO_0008572","EFO_1001006","EFO_0007067","EFO_0009516","Orphanet_881","EFO_1001250"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1964 and has 8 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200477","canonicalSmiles":"O=c1[n-]cnc2[nH]ncc12.[Na+]","inchiKey":"PTJRZVJXXNYNLN-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"ALLOPURINOL SODIUM","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1467","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Allopurinol sodium","Aloprim"],"synonyms":["Allopurinol sodium","Allopurinol sodium salt","NSC-108836"],"crossReferences":{"DailyMed":["allopurinol%20sodium"]},"linkedTargets":{"rows":["ENSG00000158125"],"count":1},"linkedDiseases":{"rows":["EFO_0000565","EFO_0004274","EFO_0000574","EFO_1001793","EFO_0000311"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1996."}
{"id":"CHEMBL1200509","canonicalSmiles":"CC(=O)O.CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc1cn(Cc2ccccc2)cn1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1","inchiKey":"OWAUGAMNPZHEOJ-YKZVIGSYSA-N","drugType":"Protein","blackBoxWarning":false,"name":"HISTRELIN ACETATE","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201255","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Supprelin","Supprelin la","Vantas"],"synonyms":["Histrelin acetate"],"crossReferences":{"DailyMed":["histrelin%20acetate"]},"count":1,"linkedTargets":{"rows":["ENSG00000109163"],"count":1},"linkedDiseases":{"rows":["EFO_0000673"],"count":1},"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1991 and has 1 investigational indication."}
{"id":"CHEMBL1200521","canonicalSmiles":"CN(C)CCc1c[nH]c2ccc(CS(=O)(=O)N3CCCC3)cc12.O=C(O)CC(O)C(=O)O","inchiKey":"QHATUKWEVNMHRY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALMOTRIPTAN MALATE","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1505","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Almotriptan malate","Axert"],"synonyms":["Almotriptan malate","Almotriptan maleate","LAS 31416 D,L-MALATE ACID","LAS-31416","LAS-31416 D,L-MALATE ACID","LAS-31416-D,L-MALATE-ACID","PNU-180638E"],"crossReferences":{"DailyMed":["almotriptan%20malate"],"chEBI":["53781"]},"count":1,"approvedIndications":["EFO_0003821"],"linkedTargets":{"rows":["ENSG00000135312","ENSG00000179546","ENSG00000179097"],"count":3},"linkedDiseases":{"rows":["EFO_0003821"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2001 and is indicated for migraine disorder."}
{"id":"CHEMBL1200637","canonicalSmiles":"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)([O-])O.[Na+]","inchiKey":"MQRFYYBWKRACSJ-WKSAPEMMSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXAMETHASONE SODIUM PHOSPHATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1201302","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Dexacen-4","Dexacort","Dexair","Dexamethasone","Dexamethasone Sodium Phosphate","Hexadrol","Maxidex"],"synonyms":[],"crossReferences":{"PubChem":["26663018","855520"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200711","canonicalSmiles":"CC/C=C\\C/C=C\\C/C=C\\C/C=C\\C/C=C\\C/C=C\\CCC(=O)OCC.CC/C=C\\C/C=C\\C/C=C\\C/C=C\\C/C=C\\CCCC(=O)OCC","inchiKey":"DTMGIJFHGGCSLO-FIAQIACWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OMEGA-3-ACID ETHYL ESTERS","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dualtis","Lovaza","Nebbaro","Omacor","Omega-3-acid ethyl esters","Omtryg","Prestylon","Teromeg"],"synonyms":["Doconexent (dha ethyl ester)","Icosapent (epa ethyl ester)","K-85","K85","Omega-3 acid ethyl esters","Omega-3 marine triglycerides","Omega-3-acid ethyl ester","Omega-3-acid ethyl esters","Omega-3-acid ethyl esters type a","TAK-085"],"crossReferences":{"DailyMed":["omega-3-acid%20ethyl%20esters","omega-3-acid%20ethyl%20esters%20type%20a"]},"count":61,"approvedIndications":["EFO_0000319","EFO_0001360"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and is indicated for cardiovascular disease and type ii diabetes mellitus and has 59 investigational indications."}
{"id":"CHEMBL1200755","canonicalSmiles":"CCNCC.CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(OS(=O)(=O)O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCC(=O)N1)[C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O","inchiKey":"FHDKSYKZXIFRKJ-CBCFNHQSSA-N","drugType":"Protein","blackBoxWarning":false,"name":"CERULETIDE DIETHYLAMINE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201355","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tymtran"],"synonyms":["Ceruletide diethylamine"],"crossReferences":{"chEBI":["59223"]},"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200817","canonicalSmiles":"CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(c1ccccc1)c1ccccc1.Cl","inchiKey":"UXBPQRGCVJOTNT-COBSGTNCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVOMETHADYL ACETATE HYDROCHLORIDE","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1514","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["European Union"," United States"],"classes":["Cardiotoxicity"],"year":2001},"tradeNames":["Orlaam"],"synonyms":["LAAM","Levomethadyl acetate hydrochloride","MK-790","MK790"],"crossReferences":{"PubChem":["85273814"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1993. It was withdrawn in European Union and  United States initially in 2001 due to Cardiotoxicity."}
{"id":"CHEMBL1200818","canonicalSmiles":"CNC[C@H](O)c1ccc(O)c(O)c1.O=C(O)[C@H](O)[C@@H](O)C(=O)O","inchiKey":"YLXIPWWIOISBDD-NDAAPVSOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1200818","maximumClinicalTrialPhase":0,"parentId":"CHEMBL679","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144210037"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1201015","canonicalSmiles":"CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].[Al+3]","inchiKey":"WCOATMADISNSBV-UHFFFAOYSA-K","drugType":"Small molecule","blackBoxWarning":false,"name":"ALUMINUM ACETATE","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Buro-sol concentrate","Domeboro"],"synonyms":["Aluminium acetate","Aluminum acetate"],"crossReferences":{"DrugCentral":["4998"],"drugbank":["DB14518"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1976."}
{"id":"CHEMBL1201065","canonicalSmiles":"C=CCC1(C(C)CCC)C(=O)N=C([S-])NC1=O.[Na+]","inchiKey":"LYZGJWXNOGIVQA-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"THIAMYLAL SODIUM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL440","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Surital"],"synonyms":["Thiamylal sodium"],"crossReferences":{"PubChem":["144205070","26749789"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201068","canonicalSmiles":"CCC(=O)c1ccc2c(c1)N(CC(C)N(C)C)c1ccccc1S2.Cl","inchiKey":"UGVNGSMLNPWNNA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPIOMAZINE HYDROCHLORIDE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201210","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Largon"],"synonyms":["Propiomazine HCl","Propiomazine hydrochloride"],"crossReferences":{"chEBI":["8492"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1960."}
{"id":"CHEMBL1201134","canonicalSmiles":"CCCCC(F)(F)[C@@]1(O)CC[C@H]2[C@@H](CC(=O)[C@@H]2CCCCCCC(=O)O)O1","inchiKey":"WGFOBBZOWHGYQH-MXHNKVEKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LUBIPROSTONE","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amitiza"],"synonyms":["Lubiprostone","RU-0211"],"crossReferences":{"DailyMed":["lubiprostone"],"PubChem":["144206539"],"Wikipedia":["Lubiprostone"],"drugbank":["DB01046"]},"count":3,"approvedIndications":["EFO_0000555","HP_0002019"],"linkedTargets":{"rows":["ENSG00000114859"],"count":1},"linkedDiseases":{"rows":["MONDO_0004880","EFO_0000555","EFO_0002508","EFO_0000764","HP_0002019"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and is indicated for irritable bowel syndrome and constipation and has 1 investigational indication."}
{"id":"CHEMBL1201232","canonicalSmiles":"CC(C)[N+](C)(CCC(C(N)=O)(c1ccccc1)c1ccccc1)C(C)C","inchiKey":"JTPUMZTWMWIVPA-UHFFFAOYSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOPROPAMIDE","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Isopropamide"],"crossReferences":{"PubChem":["11112197","144203913","170465291"],"Wikipedia":["Isopropamide"],"drugbank":["DB01625"],"chEBI":["6043"]},"childChemblIds":["CHEMBL1200347"],"count":1,"approvedIndications":["EFO_0010282"],"linkedTargets":{"rows":["ENSG00000133019","ENSG00000168539"],"count":2},"linkedDiseases":{"rows":["EFO_0010282"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1957 and is indicated for gastrointestinal disease."}
{"id":"CHEMBL1201444","drugType":"Small molecule","blackBoxWarning":false,"name":"CRYPTENAMINE ACETATES","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Unitensen"],"synonyms":["Cryptenamine acetates"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201481","drugType":"Small molecule","blackBoxWarning":false,"name":"PORFIMER SODIUM","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Photofrin"],"synonyms":["CL 184,116","CL-184,116","CL-184116","Porfimer sodium"],"crossReferences":{"DailyMed":["porfimer%20sodium"]},"count":13,"approvedIndications":["EFO_0000616"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and is indicated for neoplasm and has 12 investigational indications."}
{"id":"CHEMBL1201532","drugType":"Unknown","blackBoxWarning":false,"name":"THYROTROPIN","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Thytropar"],"synonyms":["Thyrotrophin","Thyrotropin"],"count":3,"linkedTargets":{"rows":["ENSG00000165409"],"count":1},"linkedDiseases":{"rows":["EFO_0006859","EFO_0000501","EFO_0000641"],"count":3},"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1953 and has 3 investigational indications."}
{"id":"CHEMBL1201599","drugType":"Unknown","blackBoxWarning":false,"name":"GLOBULIN, IMMUNE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Baygam","Flebogamma","Gammagard","Gammagee","Gammar","Gammar-p i.v.","Gamulin","Gamunex","Immu-g","Immuglobin","Octagam","Sandoglobulin","Venoglobulin-i","Venoglobulin-s"],"synonyms":["Globulin, immune","Globulin, immune human serum","Immune globulin (human)"],"count":50,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 50 investigational indications."}
{"id":"CHEMBL1201650","drugType":"Unknown","blackBoxWarning":false,"name":"THYROGLOBULIN","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Proloid","Thyroglobulin"],"synonyms":["Thyroglobulin"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of IV that was first approved in 1982 and has 1 investigational indication."}
{"id":"CHEMBL1201668","drugType":"Protein","blackBoxWarning":false,"name":"NESIRITIDE","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Natrecor"],"synonyms":["C01DX19","Nesiritide","Nesiritide Recombinant","Nesiritide recombinant"],"crossReferences":{"Wikipedia":["Nesiritide"]},"count":12,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000169418"],"count":1},"linkedDiseases":{"rows":["HP_0002094","MONDO_0005149","EFO_0003086","EFO_0000756","EFO_0001645","HP_0001919","EFO_0000318","EFO_0000373","EFO_0000319","EFO_0001073","EFO_1002048","EFO_0000537","EFO_0003144","EFO_0008583","EFO_0000612","EFO_0000400","HP_0030680","EFO_0005672","HP_0000842","EFO_1000899"],"count":20},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and is indicated for cardiovascular disease and has 11 investigational indications."}
{"id":"CHEMBL1201836","drugType":"Antibody","blackBoxWarning":true,"name":"OFATUMUMAB","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Arzerra"],"synonyms":["2F2","GSK-1841157","GSK1841157","HUMAX-CD20","HUMAX-CD20 2F2","HUMAX-CD20, 2F2","HUMAX-CD20-2F2","Ofatumumab"],"crossReferences":{"DailyMed":["ofatumumab"],"DrugCentral":["4951"],"Wikipedia":["Ofatumumab"]},"count":25,"approvedIndications":["EFO_0000616","EFO_0000095","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000156738"],"count":1},"linkedDiseases":{"rows":["EFO_0009441","MONDO_0013730","EFO_0000616","EFO_0000685","MONDO_0000873","EFO_0000765","EFO_0000220","EFO_0000756","EFO_0000403","MONDO_0000870","EFO_1001469","EFO_0005952","MONDO_0003541","EFO_0000311","EFO_0000565","EFO_0003885","EFO_0000309","MONDO_0001023","EFO_0000095","EFO_0004289","EFO_0004255","EFO_0000574","MONDO_0018906","EFO_0000183","EFO_1000749","MONDO_0002083","EFO_0004719"],"count":27},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and has 3 approved and 22 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1206232","canonicalSmiles":"COc1ccc(/C=C\\c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)(O)O","inchiKey":"WDOGQTQEKVLZIJ-WAYWQWQTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSBRETABULIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Combretastatin a-4 phosphate","Fosbretabulin"],"crossReferences":{"drugbank":["DB12577"]},"childChemblIds":["CHEMBL2105643","CHEMBL1972559","CHEMBL289351","CHEMBL263994"],"count":4,"linkedTargets":{"rows":["ENSG00000261456","ENSG00000167553","ENSG00000127824","ENSG00000188229","ENSG00000198033","ENSG00000258947","ENSG00000152086","ENSG00000196230","ENSG00000104833","ENSG00000167552","ENSG00000137267","ENSG00000101162","ENSG00000123416","ENSG00000137285","ENSG00000176014"],"count":15},"linkedDiseases":{"rows":["EFO_0000616","EFO_0004683","EFO_0006859","MONDO_0002108","EFO_1001901","MONDO_0008170","EFO_0000311"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1213033","canonicalSmiles":"CCN(CC)CCCN(c1ccccc1)C1Cc2ccccc2C1","inchiKey":"NZLBHDRPUJLHCE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APRINDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aprindine","COMPOUND 99170"],"crossReferences":{"PubChem":["50112831","90340712"],"Wikipedia":["Aprindine"],"drugbank":["DB01429"]},"childChemblIds":["CHEMBL2104501"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1213529","canonicalSmiles":"C=CC(=O)O","inchiKey":"NIXOWILDQLNWCW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACRYLIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acrylic Acid"],"crossReferences":{"PubChem":["144205925","29218004"],"Wikipedia":["Acrylic_acid"],"drugbank":["DB02579"],"chEBI":["18308"]},"childChemblIds":["CHEMBL3184669","CHEMBL3185326"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL12137","canonicalSmiles":"CC(=O)OC(C)C[N+](C)(C)C.[I-]","inchiKey":"LCQWLOBDIMPRBS-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL12137","maximumClinicalTrialPhase":0,"parentId":"CHEMBL978","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231099","canonicalSmiles":"O=C(NC(=O)c1cc(F)c(F)cc1Cl)Nc1cc(F)ccc1N1CCC(C(=O)O)CC1","inchiKey":"KAJJGOCSAXKXBD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231099","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144210573"],"drugbank":["DB07396"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231375","canonicalSmiles":"Cc1cccc2c1C(=O)[C@]1(O)CCN(c3ccccc3)C1=N2","inchiKey":"NJBBBRZNBVLTRZ-GOSISDBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231375","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07468"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231498","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OCCCCC[C@@H]2SC[C@@H]3NC(=O)N[C@H]23)[C@@H](O)[C@H]1O","inchiKey":"KBOGUFFJCBPJEH-SQGSUPJISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231498","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04651"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231529","canonicalSmiles":"Cc1c(N)nc([C@H](CC(N)=O)NC[C@H](N)C(N)=O)nc1C(=O)N[C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@H](C(=O)NCCc1nc(-c2nc(C(=O)NCCCNCCCCNCCCN)cs2)cs1)[C@@H](C)O)[C@@H](O[C@@H]1O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]1O)c1c[nH]cn1","inchiKey":"FOUFFVYWFNBHHH-YNGSZULRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BLEOMYCIN A6","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bleomycin a6","Boanmycin"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1231667","canonicalSmiles":"CC1=C(C(=O)Nc2ccccc2)SCCO1","inchiKey":"GYSSRZJIHXQEHQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBOXIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DNDI1724944"],"crossReferences":{"PubChem":["144209186","144211023","26752286","4264006"],"drugbank":["DB04657"],"chEBI":["3405"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231683","canonicalSmiles":"CC(C)Nc1ccc2cnn(-c3cncc(-n4ccc(CC(=O)O)c4)n3)c2c1","inchiKey":"BBYRUZKRFAIQSR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231683","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07546"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232817","canonicalSmiles":"O=CN1CCCCC1","inchiKey":"FEWLNYSYJNLUOO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232817","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144212424"],"drugbank":["DB04113"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233278","canonicalSmiles":"OCCSSCCO","inchiKey":"KYNFOMQIXZUKRK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1233278","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144212498"],"drugbank":["DB02486"],"chEBI":["43136"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234048","canonicalSmiles":"CCCCCCCCCCCCO[C@H]1O[C@H](CO)[C@@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O","inchiKey":"NLEBIOOXCVAHBD-YHBSTRCHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234048","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03279"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235115","canonicalSmiles":"O=C(COP(=O)(O)O)[C@@H](O)[C@@H](O)[C@H](O)COP(=O)(O)O","inchiKey":"XPYBSIWDXQFNMH-PQLUHFTBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235115","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02512"],"chEBI":["49093"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236788","canonicalSmiles":"COc1cc(Cc2cnc(N)nc2N)c2c(c1OC)O[C@H](C1CC1)C=C2","inchiKey":"HWJPWWYTGBZDEG-AWEZNQCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(R)-ICLAPRIM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(R)-Iclaprim"],"crossReferences":{"drugbank":["DB08741"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1237210","canonicalSmiles":"CC(C)=CCC[C@]1(C)[C@@H](CC=C(C)C)C[C@]2(CC=C(C)C)C(=O)C(CC=C(C)C)=C(O)[C@@]1(C(=O)C(C)C)C2=O","inchiKey":"IWBJJCOKGLUQIZ-HQKKAZOISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1237210","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["Hyperforin"],"drugbank":["DB01892"],"chEBI":["5834"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1241348","canonicalSmiles":"C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H](Oc2cc(-c3csc(NC(=O)C(C)C)n3)nc3c(Br)c(OC)ccc23)CN1C(=O)[C@@H](NC(=O)OC1CCCC1)C(C)(C)C)C(=O)O","inchiKey":"LLGDPTDZOVKFDU-XUHJSTDZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FALDAPREVIR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BI 201335","BI-201335","BI201335","Faldaprevir"],"crossReferences":{"drugbank":["DB11808"]},"childChemblIds":["CHEMBL3544915"],"count":5,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL125","canonicalSmiles":"CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C","inchiKey":"PQLXHQMOHUQAKB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MILTEFOSINE","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Impavido","Miltefosine","Miltex"],"synonyms":["D-18506","HDPC","Miltefosine","NSC-605583"],"crossReferences":{"DailyMed":["miltefosine"],"PubChem":["144205019","170465622","26749044","484338"],"Wikipedia":["Miltefosine"],"drugbank":["DB09031"],"chEBI":["75283"]},"count":6,"approvedIndications":["DOID_10113","EFO_0005044","EFO_0007379","EFO_0005046","EFO_0005045"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and has 5 approved and 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL126726","canonicalSmiles":"CC1(C)N=C(N)N=C(N)N1OCCCOc1ccc(Br)cc1","inchiKey":"MPXYCOHVHSXSDC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL126726","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04007"]},"childChemblIds":["CHEMBL1203258"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL130266","canonicalSmiles":"O=c1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]2O)c(=O)[nH]1","inchiKey":"XCCTYIAWTASOJW-XVFCMESISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"URIDINE_DIPHOSPHATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["UDP","Uridine 5'-Diphosphate","Uridine Diphosphate","Uridine-5'-Diphosphate"],"crossReferences":{"PubChem":["90341062"],"Wikipedia":["Uridine_diphosphate"],"drugbank":["DB03435"],"chEBI":["17659"]},"childChemblIds":["CHEMBL1457622","CHEMBL4295086","CHEMBL1096401"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL132530","canonicalSmiles":"C[C@]12CC[C@H]3[C@@H](CCC4=C(O)C(=O)CC[C@@]43C)[C@@H]1CCC2=O","inchiKey":"OSVMTWJCGUFAOD-KZQROQTASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FORMESTANE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lentaron"],"synonyms":["CGP 32349","Formestane"],"crossReferences":{"PubChem":["11532941","143659","144205664","144207058","144212603","170466203","26757799","56463214"],"Wikipedia":["Formestane"],"drugbank":["DB08905"],"chEBI":["75172"]},"count":1,"approvedIndications":["EFO_0000616"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for neoplasm."}
{"id":"CHEMBL1328898","canonicalSmiles":"COC(=O)[C@@H](N)Cc1ccc(O)c(O)c1","inchiKey":"XBBDACCLCFWBSI-ZETCQYMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MELEVODOPA","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CHF-1301","Melevodopa"],"crossReferences":{"PubChem":["11111051","50111022","90341190"],"drugbank":["DB13313"]},"childChemblIds":["CHEMBL1255756"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1351","drugType":"Small molecule","blackBoxWarning":true,"name":"CARBOPLATIN","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Carboplatin","Paraplatin"],"synonyms":["Carboplatin","JM-8","NSC-201345","NSC-241240","Paraplatin"],"crossReferences":{"DailyMed":["carboplatin"],"DrugCentral":["4133"],"PubChem":["26748613","26748614","26748615","50110983"],"TG-GATEs":["133"],"chEBI":["31355"]},"count":162,"approvedIndications":["EFO_0000616","Orphanet_398934","EFO_0003893","EFO_0001075","MONDO_0008170","EFO_0000311"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1989 and has 6 approved and 156 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL136478","drugType":"Small molecule","blackBoxWarning":true,"name":"SODIUM NITROPRUSSIDE","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2097081","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nipride","Nitropress","Sodium nitroprusside"],"synonyms":["Nitroprusside sodium","Sodium nitroferricyanide","Sodium nitroprusside","Sodium nitroprusside dihydrate","Sodium nitroprusside hydrate"],"crossReferences":{"DailyMed":["sodium%20nitroprusside"],"Wikipedia":["Sodium_nitroprusside"],"chEBI":["29321"]},"count":9,"linkedTargets":{"rows":["ENSG00000061918","ENSG00000123201"],"count":2},"linkedDiseases":{"rows":["EFO_1000653","MP_0001845","GO_0007568","EFO_0004517","EFO_0008585","EFO_0003144","EFO_0004272","EFO_0000319","EFO_0001358","EFO_0000692","EFO_0000537"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and has 9 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1375743","canonicalSmiles":"Cl.O.O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1","inchiKey":"ZCBZSCBNOOIHFP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ZIPRASIDONE HYDROCHLORIDE","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL708","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Geodon","Zeldox","Ziprasidone hydrochloride"],"synonyms":["CP-88,059-1","CP-88059-1","CP-880591","Ziprasidone hydrochloride","Ziprasidone hydrochloride hydrate","Ziprasidone hydrochloride monohydrate"],"crossReferences":{"DailyMed":["ziprasidone%20hydrochloride"],"PubChem":["90340940"],"chEBI":["32314"]},"count":1,"approvedIndications":["EFO_0000289"],"linkedTargets":{"rows":["ENSG00000149295","ENSG00000102468","ENSG00000147246"],"count":3},"linkedDiseases":{"rows":["EFO_0000289"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2001 and is indicated for bipolar disorder. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1407943","canonicalSmiles":"Clc1ccc(Cn2c(CN3CCCC3)nc3ccccc32)cc1","inchiKey":"CJXAEXPPLWQRFR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLEMIZOLE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AL 20 [AS HYDROCHLORIDE]","AL-20 FREE BASE","Clemizole","Clemizole hydrochloride","NSC-46261"],"crossReferences":{"PubChem":["11110952","11110953","90341639"],"Wikipedia":["Clemizole"],"chEBI":["52140"]},"childChemblIds":["CHEMBL3216363","CHEMBL1256817"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL145","canonicalSmiles":"O=C(O)/C=C/c1ccc(O)c(O)c1","inchiKey":"QAIPRVGONGVQAS-DUXPYHPUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CAFFEIC ACID","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-PROPENOIC ACID, 3-(3,4-DIHYDROXYPHENYL)-, (2E)-","Caffeic acid","NSC-57197","NSC-623438","trans-Caffeate"],"crossReferences":{"PubChem":["106262","124883134","124883135","124883138","26746990","26751505","50104061","50104062","50104063","50104064","50104065","56422203","85231345","855772","90340699"],"Wikipedia":["Caffeic_acid"],"drugbank":["DB01880"],"chEBI":["16433"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL148333","canonicalSmiles":"CNCCNS(=O)(=O)c1cccc2cnccc12","inchiKey":"PJWUXKNZVMEPPH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL148333","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11111503","124880801","26755703"],"drugbank":["DB07997"],"chEBI":["43561"]},"childChemblIds":["CHEMBL1395058"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL151","canonicalSmiles":"O=c1cc(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12","inchiKey":"IQPNAANSBPBGFQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LUTEOLIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Digitoflavone","Flacitran","Luteolin","Luteoline","Luteolol"],"crossReferences":{"PubChem":["11112366","11112367","124882293","124882294","124882295","26725303","26754151","26754152","46500347","56463543","85256900"],"Wikipedia":["Luteolin"],"drugbank":["DB15584"],"chEBI":["15864"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL1521","canonicalSmiles":"CCN(C(C)=O)c1cccc(-c2ccnc3c(C#N)cnn23)c1","inchiKey":"HUNXMJYCHXQEGX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ZALEPLON","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sonata","Zaleplon"],"synonyms":["CL 284,846","CL-284846","L-846","L846","LJC 10846","LJC-10846","SKP-1041","ZAL-846","Zaleplon","Zaleplon civ"],"crossReferences":{"DailyMed":["zaleplon"],"PubChem":["144205425","170465168","26719706","29216208"],"Wikipedia":["Zaleplon"],"drugbank":["DB00962"],"chEBI":["10102"]},"count":5,"linkedTargets":{"rows":["ENSG00000113327","ENSG00000163288"],"count":2},"linkedDiseases":{"rows":["EFO_0001072","MONDO_0002050","HP_0000726","EFO_0005230","EFO_0004698","EFO_0000692"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and has 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1556918","canonicalSmiles":"Cc1ccc(C(=O)c2ccc(CC(=O)[O-])n2C)cc1.O.[Na+]","inchiKey":"BMSZSJMGNZHKRE-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1556918","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1020","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["56463062"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1589896","canonicalSmiles":"Oc1ccc(C(O)CNCCCCCCNCC(O)c2ccc(O)c(O)c2)cc1O","inchiKey":"OXLZNBCNGJWPRV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HEXOPRENALINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hexoprenaline"],"crossReferences":{"PubChem":["50112775"],"drugbank":["DB08957"]},"childChemblIds":["CHEMBL2104813"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1614701","canonicalSmiles":"Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21","inchiKey":"CYOHGALHFOKKQC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SELUMETINIB","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["ARRY-142886","ARRY-886","AZD-6244","AZD6244","Azd-6244","Selumetinib"],"crossReferences":{"DailyMed":["selumetinib%20sulfate"],"PubChem":["144206913","170466898","174006431"],"drugbank":["DB11689"],"chEBI":["90227"]},"childChemblIds":["CHEMBL2105684"],"count":40,"linkedTargets":{"rows":["ENSG00000126934","ENSG00000169032"],"count":2},"linkedDiseases":{"rows":["MONDO_0003060","EFO_0000365","EFO_0000558","EFO_0000756","EFO_1000231","MONDO_0007254","EFO_1000657","EFO_0000708","MONDO_0021063","EFO_0000228","EFO_0000272","MONDO_0001187","MONDO_0016691","EFO_1001951","EFO_1001952","EFO_1001480","EFO_1000044","EFO_0000339","EFO_0000389","MONDO_0008903","EFO_0000182","EFO_0000501","MONDO_0018531","EFO_0000641","EFO_0004606","EFO_0000707","EFO_0002617","EFO_0000616","EFO_0002618","EFO_1000616","EFO_1001956","EFO_0000503","MONDO_0021321","MONDO_0002108","EFO_0000220","EFO_0000403","Orphanet_636","EFO_1001968","EFO_0003060","EFO_0005221","EFO_0000311","EFO_1000489","MONDO_0000544","EFO_0009254","EFO_0000658","EFO_0005537","EFO_0004142","MONDO_0002367","EFO_0001378","MONDO_0024880","EFO_1001950","MONDO_0021637"],"count":52},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and has 40 investigational indications."}
{"id":"CHEMBL1614707","canonicalSmiles":"FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1","inchiKey":"ZTFBIUXIQYRUNT-MDWZMJQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MUBRITINIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mubritinib","TAK-165"],"crossReferences":{"drugbank":["DB12682"]},"count":5,"linkedTargets":{"rows":["ENSG00000141736"],"count":1},"linkedDiseases":{"rows":["EFO_0003869","EFO_0003865","EFO_0003893","EFO_0003860","MONDO_0021117"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1644029","canonicalSmiles":"O=[N+]([O-])[O-].[K+]","inchiKey":"FGIUAXJPYTZDNR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"POTASSIUM NITRATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E-252","E252","INS NO.252","INS-252","NSC-57632","Potassium nitrate"],"crossReferences":{"DrugCentral":["4263"],"PubChem":["144208779","144213706"],"Wikipedia":["Potassium_nitrate"],"drugbank":["DB11090"],"chEBI":["63043"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1707454","canonicalSmiles":"Cc1ccccc1/N=N/c1ccc(/N=N/c2c(O)ccc3ccccc23)c(C)c1","inchiKey":"RCTGMCJBQGBLKT-PAMTUDGESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SCARLET RED","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Biebrich scarlet red","C.I. 26105","CI-26105","NSC-10472","Scarlet red"],"crossReferences":{"PubChem":["144205860","170465710","29217837","539817"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1716","canonicalSmiles":"CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1.Cl","inchiKey":"ZPMVNZLARAEGHB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYPROHEPTADINE HYDROCHLORIDE","yearOfFirstApproval":1961,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL516","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cyproheptadine Hydrocloride","Cyproheptadine hydrochloride","Periactin"],"synonyms":["Cyproheptadine HCl","Cyproheptadine hydrochloride","Cyproheptadine hydrochloride hydrate","Cyproheptadine hydrochloride sesquihydrate","NSC-169911"],"crossReferences":{"DailyMed":["cyproheptadine%20hydrochloride"],"PubChem":["50105994","50105995","56422142","855651"],"chEBI":["59695"]},"count":1,"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0000311"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1961 and has 1 investigational indication."}
{"id":"CHEMBL17350","canonicalSmiles":"C[C@@H]([C@@H](O)c1ccc(O)cc1)N1CCC(O)(c2ccccc2)CC1","inchiKey":"QEMSVZNTSXPFJA-HNAYVOBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRAXOPRODIL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-101,606","CP-101606","Cp-101,606","Traxoprodil"],"crossReferences":{"Wikipedia":["Traxoprodil"]},"childChemblIds":["CHEMBL3989673"],"count":3,"linkedTargets":{"rows":["ENSG00000273079","ENSG00000176884"],"count":2},"linkedDiseases":{"rows":["MONDO_0002009","EFO_0002508","EFO_0000712"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL175105","canonicalSmiles":"C[C@]12OC(C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O","inchiKey":"UIARLYUEJFELEN-DMVVYWCZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL175105","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06469"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1789842","canonicalSmiles":"CCc1cc2c(cc1CC)CC(NC[C@H](O)c1ccc(O)c3[nH]c(=O)ccc13)C2.O=C(O)/C=C\\C(=O)O","inchiKey":"IREJFXIHXRZFER-PCBAQXHCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INDACATEROL MALEATE","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1095777","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Arcapta neohaler","Onbrez breezhaler"],"synonyms":["Indacaterol maleate","QAB-149-AFA","QAB149-AFA"],"crossReferences":{"DailyMed":["indacaterol%20maleate"],"chEBI":["68573"]},"count":4,"approvedIndications":["EFO_0000464","EFO_0006505","EFO_0000341"],"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["EFO_0000270","EFO_0000464","EFO_0006505","EFO_0000341"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and has 3 approved and 1 investigational indication."}
{"id":"CHEMBL1874750","canonicalSmiles":"COc1cc(/C=C/C(=O)N2CCN(CC(=O)N3CCCC3)CC2)cc(OC)c1OC","inchiKey":"RCUDFXMNPQNBDU-VOTSOKGWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CINEPAZIDE","yearOfFirstApproval":1980,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Spain"],"classes":["Hematological toxicity"],"year":1987},"tradeNames":[],"synonyms":["Cinepazide","Cinepazide maleate","MD 67350 FREE BASE","MD 67350 [AS MALEATE]","MD-67350 FREE BASE"],"crossReferences":{"PubChem":["50125834"],"drugbank":["DB12123"]},"childChemblIds":["CHEMBL4303265"],"count":1,"approvedIndications":["EFO_0000319"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1980 and is indicated for cardiovascular disease. It was withdrawn in Spain  in 1987 due to Hematological toxicity."}
{"id":"CHEMBL192154","canonicalSmiles":"N#Cc1cc(-c2ccc(O)c(F)c2)cc2ccc(O)cc12","inchiKey":"NSSOSHDCWCMNDM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL192154","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06875"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL193","canonicalSmiles":"COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-]","inchiKey":"HYIMSNHJOBLJNT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NIFEDIPINE","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adalat","Adalat a.r.","Adalat cc","Adalat ic","Adalat la 20","Adalat la 30","Adalat la 60","Adalat ret","Adalate lp","Adanif xl","Adipine mr 10","Adipine mr 20","Adipine xl","Afeditab cr","Angiopine 10","Angiopine 40 la","Angiopine 5","Angiopine mr 10","Angiopine mr 20","Calanif","Calchan mr 10","Calchan mr 20","Calcilat","Cardilate mr","Coracten sr","Coracten xl","Coroday mr","Fortipine la40","Genalat 10 ret","Genalat 20 ret","Hypolar ret 10","Hypolar ret 20","Hypolar xl 30","Kentipine","Kentipine mr 10","Kentipine mr 20","Neozipine xl","Nife-wolff","Nifedipine","Nifedipress mr 10","Nifedipress mr 20","Nifedotard 20 mr","Nifelease","Nifensar xl","Nifopress mr","Nifopress ret","Nimodrel mr 10","Nimodrel mr 20","Nimodrel xl","Nivaten ret","Procardia","Procardia xl","Slofedipine xl 30","Slofedipine xl 60","Tensipine mr 10","Tensipine mr 20","Unipine xl","Valni 20 ret","Valni xl","Vasad"],"synonyms":["BAY A 1040","BAY-A-1040","Nifedipine"],"crossReferences":{"DailyMed":["nifedipine"],"PubChem":["104171202","11111548","11111549","11113899","124880908","124880909","124880910","124880913","144203763","144207502","170465006","17388858","26747150","26747151","26752059","26752060","50100293","50104712","50104713","50104714","85231157","90341123"],"TG-GATEs":["91"],"Wikipedia":["Nifedipine"],"drugbank":["DB01115"],"chEBI":["7565"]},"count":14,"approvedIndications":["EFO_0000319","EFO_0000537"],"linkedTargets":{"rows":["ENSG00000157388","ENSG00000081248","ENSG00000102001","ENSG00000151067"],"count":4},"linkedDiseases":{"rows":["EFO_0007442","MONDO_0005149","EFO_0000275","HP_0000093","EFO_0000401","EFO_0000319","EFO_1000782","EFO_1001145","EFO_0000537","Orphanet_418","HP_0012390","MONDO_0012511","EFO_0003890","EFO_1001375","EFO_0004263","EFO_0004253","EFO_0003884","EFO_1002032","EFO_0003917","MONDO_0001641","EFO_0000668"],"count":21},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and is indicated for hypertension and cardiovascular disease and has 12 investigational indications."}
{"id":"CHEMBL1951095","canonicalSmiles":"CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)c(NC(=O)CN5CCCC5)cc(F)c4C[C@H]3C[C@@H]12","inchiKey":"HLFSMUUOKPBTSM-ISIOAQNYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERAVACYCLINE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tp-434"],"synonyms":["Eravacycline","TP-434"],"crossReferences":{"DailyMed":["eravacycline%20dihydrochloride"],"drugbank":["DB12329"]},"childChemblIds":["CHEMBL2219414"],"count":5,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for bacterial disease and has 4 investigational indications."}
{"id":"CHEMBL197084","canonicalSmiles":"C[C@@]1(C(=O)N[C@@H](CCC(=O)O)C(=O)O)CCCN1C(=O)CN","inchiKey":"BUSXWGRAOZQTEY-SDBXPKJASA-N","drugType":"Protein","blackBoxWarning":false,"name":"TROFINETIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Trofinetide"],"crossReferences":{"drugbank":["DB06045"]},"count":4,"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1980825","canonicalSmiles":"O=C1CC[C@H](NC(=O)Cc2ccccc2)C(=O)N1","inchiKey":"OQGRFQCUGLKSAV-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANTINEOPLASTON A10","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Antineoplaston a 10","Antineoplaston a10","Atengenal"],"crossReferences":{"PubChem":["489176"],"drugbank":["DB11702"]},"count":42,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 42 investigational indications."}
{"id":"CHEMBL2021430","canonicalSmiles":"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)([O-])[O-].[Na+].[Na+]","inchiKey":"PLCQGRYPOISRTQ-FCJDYXGNSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXAMETHASONE SODIUM PHOSPHATE","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201302","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Decadron","Dexacen-4","Dexacort","Dexair","Dexamethasone","Dexamethasone sodium phosphate","Dexamethasone sodium phosphate preservative free","Hexadrol","Maxidex"],"synonyms":["Dexamethasone 21-phosphate disodium salt","Dexamethasone sodium phosphate","TLC-399","TLC399","Tlc399"],"crossReferences":{"DailyMed":["dexamethasone%20sodium%20phosphate"],"PubChem":["144206732","144212903"],"chEBI":["4462"]},"count":69,"approvedIndications":["EFO_0000729","EFO_1000845","EFO_0004274","EFO_0005558","EFO_0008997","EFO_0000565","EFO_0007160","EFO_0009456","EFO_0007520","EFO_0002506","EFO_0002690","EFO_0004255","EFO_0000676","EFO_0009552","EFO_0004276","EFO_0004719","HP_0003072","EFO_0005854","EFO_0009449","EFO_1000039","HP_0001742","HP_0001873","EFO_0000384","EFO_1001119","MP_0001845","EFO_1000049","Orphanet_90794","EFO_0000270","EFO_0000574","EFO_1001051","HP_0012424","EFO_1001896","EFO_0007405","EFO_1001205","EFO_0005319","EFO_1000997","EFO_1000764","MONDO_0001280","EFO_1001435","HP_0001094","EFO_0003778","EFO_1000684","EFO_0000274","HP_0001915","HP_0004398","EFO_1000694","EFO_0005752","EFO_0009609","Orphanet_797","EFO_0000685","MONDO_0015128","EFO_0003898","EFO_0003894","EFO_1000941","EFO_0002609","EFO_0003106","EFO_0007257","EFO_0007403","EFO_1001194","EFO_0007141","EFO_0003956"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_1000845","EFO_0000729","EFO_0010822","MONDO_0017634","EFO_0004274","MONDO_0002959","EFO_0005558","EFO_0005773","EFO_0008997","EFO_0000565","EFO_0007160","EFO_0009456","EFO_0007520","EFO_0002506","EFO_0002690","EFO_0004255","EFO_0000676","EFO_0009552","EFO_0004276","EFO_1001250","EFO_0004719","HP_0003072","EFO_0005854","EFO_0009449","EFO_0001642","EFO_1000039","HP_0001742","EFO_0000384","HP_0001873","EFO_1001119","MP_0001845","HP_0003040","EFO_1000049","Orphanet_90794","EFO_0000270","EFO_0000574","EFO_1001051","HP_0012424","EFO_0001378","EFO_1001896","EFO_0007405","EFO_1001205","EFO_1000997","EFO_0005319","EFO_1000764","EFO_1001435","MONDO_0001280","HP_0001094","EFO_0009509","EFO_1000684","EFO_0003778","EFO_0000274","HP_0001915","HP_0004398","EFO_1000694","EFO_0005752","EFO_0007490","EFO_0009609","Orphanet_797","EFO_0000685","MONDO_0015128","EFO_0003898","EFO_0000556","EFO_0003929","EFO_0001358","EFO_0003894","EFO_0003843","EFO_1000941","EFO_0002609","EFO_0006738","EFO_0003106","EFO_0007257","EFO_0007403","EFO_1001194","EFO_0007141","EFO_0004265","EFO_0003956"],"count":77},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1959 and has 61 approved and 8 investigational indications."}
{"id":"CHEMBL20684","canonicalSmiles":"COc1ccc(S(=O)(=O)Nc2cccnc2Nc2ccc(O)cc2)cc1","inchiKey":"URCVCIZFVQDVPM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABT-751","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Abt-751","E 7010","E-7010"],"crossReferences":{"drugbank":["DB12254"]},"childChemblIds":["CHEMBL1830238"],"count":8,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL207228","canonicalSmiles":"Cc1nn(C)c2c1c(=O)c1cc(Cl)ccc1n2O","inchiKey":"AYKGPCNWPACUQV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL207228","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07218"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL207413","canonicalSmiles":"CC(=O)O[C@H]1CC[C@@]2(C)[C@@H](CC[C@]3(C)[C@@H]2C(=O)C=C2[C@@H]4C[C@@](C)(C(=O)O)CC[C@]4(C)CC[C@]23C)C1(C)C","inchiKey":"FTQDJVZNPJRVPG-XWEVEMRCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACETOXOLONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acetoxolone"],"crossReferences":{"Wikipedia":["Acetoxolone"],"drugbank":["DB13640"],"chEBI":["81306"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL209720","canonicalSmiles":"O=c1ccn([C@H]2C[C@H](F)[C@@H](COC(c3ccccc3)(c3ccccc3)c3ccccc3)O2)c(=O)[nH]1","inchiKey":"GJNIPWYJQUGERM-BFLUCZKCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL209720","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04685"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2103735","canonicalSmiles":"CC(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](Cc1cccnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](CCCNC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O.CC(=O)O","inchiKey":"KFEFLCOCAHJBEA-ANRVCLKPSA-N","drugType":"Protein","blackBoxWarning":false,"name":"CETRORELIX ACETATE","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1200490","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cetrotide"],"synonyms":["Cetrorelix","Cetrorelix acetate","D-20761","NS-75A","SB-075 ACETATE"],"crossReferences":{"chEBI":["31387"]},"count":2,"linkedTargets":{"rows":["ENSG00000109163"],"count":1},"linkedDiseases":{"rows":["EFO_0000545","EFO_0000731","EFO_0000660"],"count":3},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and has 2 investigational indications."}
{"id":"CHEMBL2103855","canonicalSmiles":"Cc1ccn(-c2cc(Cl)ccc2[C@@H](Oc2cc(-c3ccc(C[C@H](N)C(=O)O)cc3)nc(N)n2)C(F)(F)F)n1","inchiKey":"NCLGDOBQAWBXRA-PGRDOPGGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TELOTRISTAT","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["LP 778902","LP-778902","Telotristat"],"crossReferences":{"drugbank":["DB14218"]},"count":4,"linkedTargets":{"rows":["ENSG00000139287","ENSG00000129167"],"count":2},"linkedDiseases":{"rows":["EFO_0000729","EFO_0003086","EFO_1001901","EFO_0001421","EFO_1000852"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2103914","canonicalSmiles":"O=c1[nH]sc2cc(Cl)ccc12","inchiKey":"POPOYOKQQAEISW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TICLATONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FER-1443","Ticlatone"],"crossReferences":{"PubChem":["170466391"],"drugbank":["DB13613"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104986","canonicalSmiles":"Cc1ccc(Sc2ccccc2C2CCNCC2)cc1","inchiKey":"CVASBKDYSQKLSO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEDATIOXETINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LU AA24530","LU-AA24530","Lu aa24530","Tedatioxetine"],"crossReferences":{"drugbank":["DB12641"]},"childChemblIds":["CHEMBL2107377"],"count":1,"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546","ENSG00000149305","ENSG00000102468","ENSG00000186090","ENSG00000142319","ENSG00000178084","ENSG00000186038","ENSG00000120907","ENSG00000166736","ENSG00000147246"],"count":11},"linkedDiseases":{"rows":["MONDO_0002009"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2105059","canonicalSmiles":"O=C(OCCN1CCOCC1)c1cccnc1Nc1cccc(C(F)(F)F)c1","inchiKey":"LDXSPUSKBDTEKA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MORNIFLUMATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Morniflumate","UP 164"],"crossReferences":{"PubChem":["170466184"],"drugbank":["DB09285"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105080","canonicalSmiles":"COCc1c(C(=O)OC(C)C)ncc2[nH]c3cccc(Oc4ccc(Cl)cc4)c3c12","inchiKey":"SLYDYLLJUXFULK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GEDOCARNIL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gedocarnil"],"crossReferences":{"drugbank":["DB13534"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105141","canonicalSmiles":"CC(CCN1CCN(c2ccc(F)cc2)CC1)NC(=O)c1cccnc1","inchiKey":"RSKQGBFMNPDPLR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NIAPRAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1709 CERM","Niaprazine"],"crossReferences":{"drugbank":["DB13687"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105668","canonicalSmiles":"Cc1cc(F)ccc1[C@H]1C[C@@H](N2CCN3C(=O)CC[C@H]3C2)CCN1C(=O)N(C)[C@H](C)c1cc(C(F)(F)F)cc(C(F)(F)F)c1.O=C(O)/C=C\\C(=O)O","inchiKey":"IPACOHTZCSBGBV-WUXDIRCFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ORVEPITANT MALEATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2105667","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GW-823296B","GW823296B","Orvepitant maleate"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2105728","canonicalSmiles":"CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1","inchiKey":"DYNHJHQFHQTFTP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CRENOLANIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ARO 002","ARO-002","CP 868596","CP-868,596","CP-868596","Crenolanib"],"crossReferences":{"drugbank":["DB11832"]},"childChemblIds":["CHEMBL2146086"],"count":6,"linkedTargets":{"rows":["ENSG00000134853","ENSG00000113721","ENSG00000122025"],"count":3},"linkedDiseases":{"rows":["EFO_1000026","EFO_0000616","EFO_0000503","Orphanet_44890","EFO_0000326","EFO_0000222","EFO_0000519"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2105754","canonicalSmiles":"Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2cc(F)ccc2C#N)c1=O.O=C(O)CCC(=O)O","inchiKey":"OGCNTTUPLQTBJI-XFULWGLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRELAGLIPTIN SUCCINATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1650443","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SYR-111472 SUCCINATE","SYR-472","SYR111472 SUCCINATE","Trelagliptin succinate"],"count":2,"linkedTargets":{"rows":["ENSG00000197635"],"count":1},"linkedDiseases":{"rows":["EFO_0001360","EFO_0000400"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2106388","canonicalSmiles":"[Ca+2].[OH-].[OH-]","inchiKey":"AXCZMVOFGPJBDE-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CALCIUM HYDROXIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Calcium hydroxide","E-526","INS NO.526","INS-526"],"crossReferences":{"chEBI":["31341"]},"count":4,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2106561","canonicalSmiles":"CCOC(=O)NNc1ccc(N(CC)CC(C)O)nn1","inchiKey":"QLTVVOATEHFXLT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CADRALAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cadralazine"],"crossReferences":{"PubChem":["144206697","170466021"],"drugbank":["DB13452"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2107112","canonicalSmiles":"CC(C)(C)C(=O)SCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C","inchiKey":"BISFDZNIUZIKJD-XDANTLIUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIXOCORTOL PIVALATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tixocortol","Tixocortol pivalate"],"crossReferences":{"chEBI":["63564"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2107756","canonicalSmiles":"C=CC1=C(C)c2cc3[nH]c(cc4nc(cc5[nH]c(cc1n2)c(C)c5CCC(=O)OCCC)C(CCC(=O)OCCO)=C4C)C1(C)C3=CC=C(C(=O)OC)C1C(=O)OC","inchiKey":"LHXFPSQJODNWEW-DVNHMXKTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEMUTEPORFIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lemuteporfin","QLT-0074","QLT0074"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2107773","canonicalSmiles":"Cc1cc(OCC(=O)O)c(C)cc1CCN[C@@H](C)[C@H](O)c1ccc(O)cc1","inchiKey":"VMMYRRFPMAGXNP-BTYIYWSLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RITOBEGRON","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KUC-7483","Kuc-7483","Ritobegron"],"crossReferences":{"drugbank":["DB12080"]},"count":2,"linkedTargets":{"rows":["ENSG00000188778"],"count":1},"linkedDiseases":{"rows":["EFO_1000781","HP_0000011"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2107866","drugType":"Protein","blackBoxWarning":false,"name":"PEGINESATIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Hematide"],"synonyms":["AF-37702","AF37702","Peginesatide"],"crossReferences":{"DrugCentral":["4234"]},"count":1,"linkedTargets":{"rows":["ENSG00000187266"],"count":1},"linkedDiseases":{"rows":["EFO_0004272"],"count":1},"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108051","drugType":"Antibody","blackBoxWarning":false,"name":"STAMULUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MYO-029","Stamulumab"],"count":3,"linkedTargets":{"rows":["ENSG00000138379"],"count":1},"linkedDiseases":{"rows":["Orphanet_263","Orphanet_98895","Orphanet_269"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2108060","drugType":"Unknown","blackBoxWarning":false,"name":"VITESPEN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Oncophage"],"synonyms":["HSPPC-96","Vitespen"],"count":11,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 11 investigational indications."}
{"id":"CHEMBL2108735","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"DRISAPERSEN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Drisapersen","GSK-2402968","GSK-2402968A","GSK2402968","GSK2402968A","H51AON23","PRO-051","PRO051"],"count":2,"linkedTargets":{"rows":["ENSG00000198947"],"count":1},"linkedDiseases":{"rows":["Orphanet_98896","Orphanet_98473"],"count":2},"description":"Oligonucleotide drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108817","drugType":"Antibody","blackBoxWarning":false,"name":"YTTRIUM Y 90 EPRATUZUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Lymphocide"],"synonyms":["90Y_HLL2","Yttrium y 90 epratuzumab"],"linkedTargets":{"rows":["ENSG00000012124"],"count":1},"linkedDiseases":{"rows":["EFO_0000565","EFO_0000574"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108821","drugType":"Unknown","blackBoxWarning":false,"name":"TRYPSIN, CRYSTALLIZED","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Parenzyme"],"synonyms":["Trypsin","Trypsin, crystallized"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108939","drugType":"Unknown","blackBoxWarning":false,"name":"CHOLERA VACCINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cholera vaccine","Cholera, live attenuated"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109379","drugType":"Antibody","blackBoxWarning":false,"name":"NI-0801","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NI-0801","Ni-0801"],"count":2,"linkedTargets":{"rows":["ENSG00000169245"],"count":1},"linkedDiseases":{"rows":["EFO_1000668","EFO_1001486"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109494","drugType":"Antibody","blackBoxWarning":false,"name":"A27.15","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A27.15"],"count":4,"linkedTargets":{"rows":["ENSG00000072274"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000565","EFO_0002428","EFO_0001378"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2109535","drugType":"Antibody","blackBoxWarning":false,"name":"KBPA-101","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AR-101","KBPA-101","Kbpa-101"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109614","drugType":"Antibody","blackBoxWarning":false,"name":"MEDI-5117","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MEDI-5117","Medi 5117"],"count":1,"linkedTargets":{"rows":["ENSG00000136244"],"count":1},"linkedDiseases":{"rows":["EFO_0000685"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2110954","canonicalSmiles":"CC1(C)CC(C)(C)CC(C)(N)C1","inchiKey":"OGZQTTHDGQBLBT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NERAMEXANE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Neramexane"],"crossReferences":{"drugbank":["DB04926"]},"childChemblIds":["CHEMBL2106798"],"count":2,"linkedTargets":{"rows":["ENSG00000183454","ENSG00000161509","ENSG00000116032","ENSG00000273079","ENSG00000105464","ENSG00000174343","ENSG00000129749","ENSG00000176884","ENSG00000198785"],"count":9},"linkedDiseases":{"rows":["HP_0000360","EFO_0000249"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2146161","canonicalSmiles":"CC1=C\\[C@@H](O)CC(=O)Cc2nc(co2)C(=O)N2CCC=C2C(=O)O[C@H](C(C)C)[C@H](C)/C=C/C(=O)NC\\C=C\\1.CC[C@H]1NC(=O)[C@@H](NC(=O)c2ncccc2O)[C@@H](C)OC(=O)[C@H](c2ccccc2)NC(=O)[C@@H]2CC(=O)CCN2C(=O)[C@H](Cc2ccc(N(C)C)cc2)N(C)C(=O)[C@@H]2CCCN2C1=O","inchiKey":"YVMBAUWDIGJRNY-BESUKNQGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIKAMYCIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pyostacine"],"synonyms":["Mikamycin","Pristinamycin","RP 7293","RP-7293","SKF-7988"],"crossReferences":{"DrugCentral":["3489"]},"count":2,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for bacterial disease and has 1 investigational indication."}
{"id":"CHEMBL2181929","canonicalSmiles":"CC1(C)Oc2cc(NS(C)(=O)=O)ccc2N(c2ccc(F)cc2)C1=O","inchiKey":"AZNHWXAFPBYFGH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2181929","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15024"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL220491","canonicalSmiles":"CCN[C@H]1CN(CCCOC)S(=O)(=O)c2sc(S(N)(=O)=O)cc21","inchiKey":"HCRKCZRJWPKOAR-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BRINZOLAMIDE","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Azopt"],"synonyms":["AL-4862","Azopt","Brinzolamide"],"crossReferences":{"DailyMed":["brinzolamide"],"PubChem":["170464926","56463043"],"Wikipedia":["Brinzolamide"],"drugbank":["DB01194"],"chEBI":["3176"]},"count":4,"approvedIndications":["EFO_0004190","EFO_1001069","EFO_0000516"],"linkedTargets":{"rows":["ENSG00000104267"],"count":1},"linkedDiseases":{"rows":["EFO_0009784","EFO_0004190","EFO_1001069","EFO_0000516","HP_0000639"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and has 3 approved and 1 investigational indication."}
{"id":"CHEMBL2206292","canonicalSmiles":"CC(C)CNC(=O)[C@H]1C[C@@](F)(c2ccc(CN3CCCC3)c(F)c2)C1","inchiKey":"DJRDLCHHQYHQQK-UKIBZPOASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-03654764","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pf-03654764"],"crossReferences":{"drugbank":["DB12360"]},"count":1,"linkedTargets":{"rows":["ENSG00000101180"],"count":1},"linkedDiseases":{"rows":["EFO_0005854"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL221181","canonicalSmiles":"N#Cc1ccc2c(-c3cc4cc(CN5CCC(CN)CC5)ccc4[nH]3)n[nH]c2c1","inchiKey":"WBKUBPBCFYCSRT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL221181","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07075"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL221390","canonicalSmiles":"CC(C)(C)OC(=O)N[C@@H](CC(=O)OCc1ccccc1)C(=O)N[C@@H](CCCCNC(=O)OCc1ccccc1)C(=O)OC(C)(C)C","inchiKey":"SVNKEDMVAQBLLN-SVBPBHIXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REVERSIN 121","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Reversin 121"],"crossReferences":{"drugbank":["DB14072"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2218861","canonicalSmiles":"CCCN1CC(NS(=O)(=O)N(CC)CC)CC2Cc3c(O)cccc3CC21","inchiKey":"GDFGTRDCCWFXTG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QUINAGOLIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Quinagolide"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL222460","canonicalSmiles":"O=c1[nH]c2ccc(C(F)(F)F)cc2c(-c2cc(Cl)ccc2O)c1CCO","inchiKey":"QESHSZWKJULSAR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-223131","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bms-223131"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL23","canonicalSmiles":"COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1","inchiKey":"HSUGRBWQSSZJOP-RTWAWAEBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DILTIAZEM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cardizem","Dilt-CD","Diltiazem","Diltzac","Tiamate","Tiazac"],"crossReferences":{"DailyMed":["diltiazem%20hydrochloride"],"PubChem":["11113366","144204449","170464699","26751609","26751610","50104266","50104267","50104268","50104269","90341257"],"TG-GATEs":["92"],"Wikipedia":["Diltiazem"],"drugbank":["DB00343"],"chEBI":["101278"]},"childChemblIds":["CHEMBL1697","CHEMBL1200805"],"count":18,"approvedIndications":["EFO_0000319","EFO_0009552"],"linkedTargets":{"rows":["ENSG00000157388","ENSG00000081248","ENSG00000102001","ENSG00000151067"],"count":4},"linkedDiseases":{"rows":["EFO_0000275","EFO_0000538","EFO_0003913","HP_0012390","EFO_0003914","EFO_0003911","EFO_1001375","EFO_0003144","EFO_0009552","HP_0003124","EFO_0002687","EFO_0001645","EFO_0000701","EFO_0000319","MONDO_0024361","EFO_0003843","EFO_0000537","EFO_0000311","EFO_0000195","EFO_0003890","MONDO_0100096","MONDO_0000831","EFO_0000764","EFO_0008583","EFO_0007328","EFO_0001360","EFO_0004225","HP_0002019","EFO_0005251"],"count":29},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and is indicated for cardiovascular disease and hemorrhoid and has 16 investigational indications."}
{"id":"CHEMBL230910","canonicalSmiles":"N[C@@H](CC(=O)N1CCCNC(=O)C1CC(F)(F)F)Cc1cc(F)c(F)cc1F","inchiKey":"RMDAPSXWBVPVOG-IAPIXIRKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL230910","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07271"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL23194","canonicalSmiles":"NCCCNCCCCNCCCN","inchiKey":"PFNFFQXMRSDOHW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SPERMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-268508","Spermine"],"crossReferences":{"PubChem":["11111791","11113818","124881425","124881427","26751991","90341642"],"Wikipedia":["Spermine"],"drugbank":["DB00127"],"chEBI":["15746"]},"childChemblIds":["CHEMBL1256357","CHEMBL1556584"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL23550","canonicalSmiles":"Nc1nc(O)c2ncn([C@@H]3C[C@H](CO)[C@H]3CO)c2n1","inchiKey":"GWFOVSGRNGAGDL-FSDSQADBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LOBUCAVIR","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-180194","Lobucavir","SQ 34,514"],"crossReferences":{"drugbank":["DB12531"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2359370","drugType":"Small molecule","blackBoxWarning":false,"name":"MECOBALAMIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Asimil b-12","B-max"],"synonyms":["Mecobalamin"],"crossReferences":{"DrugCentral":["4600"],"PubChem":["144206526"]},"count":5,"approvedIndications":["EFO_0004272"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for anemia (phenotype) and has 4 investigational indications."}
{"id":"CHEMBL2364624","canonicalSmiles":"O=C(O)C[C@H]1CC[C@H](c2ccc(-c3ccc(Nc4ccc(C(F)(F)F)nc4)cn3)cc2)CC1","inchiKey":"GXALXAKNHIROPE-QAQDUYKDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRADIGASTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LCQ-908-NXA","LCQ-908NXA","LCQ908-NXA","Pradigastat"],"crossReferences":{"drugbank":["DB12866"]},"childChemblIds":["CHEMBL2364625"],"count":5,"linkedTargets":{"rows":["ENSG00000185000"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","MONDO_0018637","EFO_0003095","EFO_0001421","MONDO_0037748","EFO_0003047","EFO_0001360","HP_0002019"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL238659","canonicalSmiles":"NNC(=O)c1cn2ccc3ccccc3c2n1","inchiKey":"WSNWYZBDIKCPIG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL238659","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08758"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL241694","canonicalSmiles":"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C","inchiKey":"CHNXZKVNWQUJIB-CEGNMAFCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHISTERONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Ora-lutin","Pranone","Syngestrotabs","Trosinone"],"synonyms":["Anhydrohydroxyprogesterone","Ethisterone","NSC-9565","Pregneninolone"],"crossReferences":{"PubChem":["144204946","144205157","144212641","170466182","56422131","855561"],"Wikipedia":["Ethisterone"],"chEBI":["34749"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL275638","canonicalSmiles":"O=c1cc(-c2ccccc2)oc2ccccc12","inchiKey":"VHBFFQKBGNRLFZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLAVONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Flavone","NSC-19028"],"crossReferences":{"PubChem":["124890241","144210185","144214020","17389570","26752852","56462798"],"drugbank":["DB07776"],"chEBI":["42491"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL277474","canonicalSmiles":"Cc1cc(=O)n(-c2ccccc2)n1C","inchiKey":"VEQOALNAAJBPNY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANTIPYRINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Antipyrin","Antipyrine","NSC-7945","Phenazon","Phenazone"],"crossReferences":{"PubChem":["104171279","11112159","144203893","144208798","144213343","170465510","26753718","56320742"],"Wikipedia":["Phenazone"],"drugbank":["DB01435"],"chEBI":["31225"]},"count":5,"approvedIndications":["HP_0001945","EFO_0003843"],"linkedTargets":{"rows":["ENSG00000095303"],"count":1},"linkedDiseases":{"rows":["EFO_0000270","HP_0001945","EFO_0004992","HP_0100607","EFO_0003843"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for fever and pain and has 3 investigational indications."}
{"id":"CHEMBL279898","canonicalSmiles":"CCCn1c(=O)[nH]c(=O)c2[nH]cnc21","inchiKey":"SIQPXVQCUCHWDI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENPROFYLLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["D 4028","Enprofylline"],"crossReferences":{"PubChem":["104171214","11111643","144203783","50104067","855784","90341781"],"Wikipedia":["Enprofylline"],"drugbank":["DB00824"],"chEBI":["126237"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL282121","canonicalSmiles":"CCN(CCCCOC(=O)c1ccc(OC)c(OC)c1)C(C)Cc1ccc(OC)cc1","inchiKey":"VYVKHNNGDFVQGA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEBEVERINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Mebeverine"],"crossReferences":{"Wikipedia":["Mebeverine"],"drugbank":["DB12554"]},"childChemblIds":["CHEMBL1446650"],"count":2,"approvedIndications":["EFO_0010282"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for gastrointestinal disease and has 1 investigational indication."}
{"id":"CHEMBL29392","canonicalSmiles":"NCCCCCCCCN","inchiKey":"PWGJDPKCLMLPJW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIAMINOOCTANE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diaminooctane"],"crossReferences":{"drugbank":["DB04333"],"chEBI":["73112"]},"childChemblIds":["CHEMBL3216710"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL301141","canonicalSmiles":"O=c1cc(O)c2ccccc2o1","inchiKey":"VXIXUWQIVKSKSA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4-HYDROXYCOUMARINS","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-Hydroxycoumarin"],"crossReferences":{"PubChem":["76718"],"Wikipedia":["4-Hydroxycoumarins"],"drugbank":["DB03410"],"chEBI":["40070"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3126691","canonicalSmiles":"c1cc2c3c(c1)[C@H]1CCC[C@H]1CN3CCN[11CH2]2","inchiKey":"NPTIPEQJIDTVKR-NKVLINHGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3126691","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2110670","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL312862","canonicalSmiles":"CN[C@H]1CCc2cc(OC)c(OC)c(OC)c2-c2ccc(OC)c(=O)cc21","inchiKey":"NNJPGOLRFBJNIW-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEMECOLCINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["C-12669","Colchamine","Demecolcine","Substance f"],"crossReferences":{"PubChem":["144205849","164339377","56320682","56320683"],"Wikipedia":["Demecolcine"],"drugbank":["DB13318"],"chEBI":["4393"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3137345","drugType":"Antibody","blackBoxWarning":false,"name":"DULIGOTUZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Duligotumab","Duligotuzumab","MEHD-7945A","MEHD7945A","RG-7597","RG7597"],"count":3,"linkedTargets":{"rows":["ENSG00000146648","ENSG00000065361"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","EFO_0006859","EFO_1001951"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3183704","drugType":"Small molecule","blackBoxWarning":false,"name":"FERROUS CHLORIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ferrous chloride"],"crossReferences":{"PubChem":["144207395"],"chEBI":["30812"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3186993","canonicalSmiles":"Cl.Cl.OCCOCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1","inchiKey":"ANOMHKZSQFYSBR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROXYZINE HYDROCHLORIDE","yearOfFirstApproval":1956,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL896","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Atarax","Hydroxyzine","Hydroxyzine hydrochloride","Orgatrax","Ucerax","Vistaril"],"synonyms":["Hydroxizine chloride","Hydroxyzine dihydrochloride","Hydroxyzine hydrochloride"],"crossReferences":{"DailyMed":["hydroxyzine%20hydrochloride"],"PubChem":["26752325"],"chEBI":["5819"]},"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0003843"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1956."}
{"id":"CHEMBL3219616","canonicalSmiles":"CC[C@@]1(c2cccc(NS(C)(=O)=O)c2)[C@H]2CN(CC3(O)Cc4ccccc4C3)C[C@H]21","inchiKey":"ZBVPUFSKFGYNLC-FIDNPTQWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CP-866087","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-866,087","Cp-866,087","Cp-866087"],"crossReferences":{"drugbank":["DB12196"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3250770","canonicalSmiles":"O=S(=O)(O)O.[2H]c1c([2H])c([2H])c(C([2H])([2H])C([2H])(N)C([2H])([2H])[2H])c([2H])c1[2H]","inchiKey":"SOFQDLYSFOWTJX-KQPZAKSXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3250770","maximumClinicalTrialPhase":0,"parentId":"CHEMBL405","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3301611","canonicalSmiles":"Nc1ccncc1N.O=P(O)(O)O","inchiKey":"KAICRBBQCRKMPO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMIFAMPRIDINE PHOSPHATE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL354077","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Firdapse"],"synonyms":["3,4-DAPP","Amifampridine phosphate","DAPP"],"crossReferences":{"DailyMed":["amifampridine%20phosphate"]},"count":4,"linkedTargets":{"rows":["ENSG00000164794","ENSG00000116396","ENSG00000184408","ENSG00000162975","ENSG00000171126","ENSG00000177272","ENSG00000168263","ENSG00000053918","ENSG00000129159","ENSG00000140015","ENSG00000026559","ENSG00000143105","ENSG00000182674","ENSG00000173826","ENSG00000184156","ENSG00000185760","ENSG00000124134","ENSG00000183960","ENSG00000111262","ENSG00000102057","ENSG00000178342","ENSG00000055118","ENSG00000117013","ENSG00000170745","ENSG00000130037","ENSG00000131398","ENSG00000182255","ENSG00000075043","ENSG00000143473","ENSG00000135519","ENSG00000168418","ENSG00000158445","ENSG00000089558","ENSG00000177301","ENSG00000151079","ENSG00000166006","ENSG00000104848","ENSG00000156486","ENSG00000171385","ENSG00000184611"],"count":40},"linkedDiseases":{"rows":["EFO_0008525","Orphanet_130","EFO_0009851","EFO_0004991"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and has 4 investigational indications."}
{"id":"CHEMBL332935","canonicalSmiles":"CC[N+](C)(CC)CCC[n+]1c(-c2ccccc2)c2cc(N)ccc2c2ccc(N)cc21","inchiKey":"ZDWVWKDAWBGPDN-UHFFFAOYSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL332935","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11112704","124882535","26756863"],"drugbank":["DB02166"],"chEBI":["51246"]},"childChemblIds":["CHEMBL345124"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3335073","canonicalSmiles":"C[n+]1ccccc1/C=N/O.[Br-]","inchiKey":"UHVXAXRWEJONPZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3335073","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1420","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL336908","canonicalSmiles":"O=C(O)C(=O)Nc1ccc(I)cc1C(=O)O","inchiKey":"SHSWHSQPJKMCPN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL336908","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02662"],"chEBI":["40326"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL347862","canonicalSmiles":"NOCC(=O)O","inchiKey":"NQRKYASMKDDGHT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBOXYMETHOXYLAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aminooxy-Acetic Acid","Carboxymethoxylamine"],"crossReferences":{"PubChem":["11110738","90340597"],"Wikipedia":["Aminooxyacetic_acid"],"drugbank":["DB02079"]},"childChemblIds":["CHEMBL1255757","CHEMBL1492415"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544921","drugType":"Enzyme","blackBoxWarning":false,"name":"CERLIPONASE ALFA","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Brineura"],"synonyms":["BMN 190","BMN-190","Cerliponase alfa"],"crossReferences":{"DailyMed":["cerliponase%20alfa"]},"count":3,"approvedIndications":["Orphanet_228349","Orphanet_216","Orphanet_79263"],"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and has 3 approved indications."}
{"id":"CHEMBL3544969","drugType":"Small molecule","blackBoxWarning":false,"name":"HM-71224","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hm-71224"],"count":1,"linkedTargets":{"rows":["ENSG00000010671"],"count":1},"linkedDiseases":{"rows":["EFO_0000685"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545046","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK2849466","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gsk2849466"],"count":1,"linkedTargets":{"rows":["ENSG00000169083"],"count":1},"linkedDiseases":{"rows":["HP_0004326"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545110","canonicalSmiles":"CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1","inchiKey":"RHXHGRAEPCAFML-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIBOCICLIB","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["LEE-011","LEE-011A","LEE011","LEE011A","Lee-011","NVP-LEE011","Ribociclib"],"crossReferences":{"DailyMed":["ribociclib%20succinate"],"drugbank":["DB11730"]},"childChemblIds":["CHEMBL4468983","CHEMBL3707266"],"count":34,"linkedTargets":{"rows":["ENSG00000135446","ENSG00000105810"],"count":2},"linkedDiseases":{"rows":["EFO_0003086","EFO_0003869","MONDO_0044903","EFO_0001075","EFO_0003859","EFO_1001901","EFO_0000756","MONDO_0015686","MONDO_0007254","EFO_0000305","EFO_0003085","MONDO_0002158","EFO_1000044","EFO_0000182","EFO_1000251","EFO_0000196","EFO_0002499","EFO_0002626","MONDO_0002601","EFO_0000616","EFO_0005220","EFO_0000220","MONDO_0008170","EFO_0000313","EFO_1001968","MONDO_0008315","EFO_0003060","EFO_0000621","MONDO_0023206","EFO_0000311","EFO_1000026","EFO_1001100","EFO_0005701","EFO_0000574","EFO_0000181","EFO_0000519","EFO_0000569"],"count":37},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and has 34 investigational indications."}
{"id":"CHEMBL3545172","drugType":"Small molecule","blackBoxWarning":false,"name":"CNV2197944","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CNV2197944","Cnv2197944"],"count":1,"linkedTargets":{"rows":["ENSG00000148408"],"count":1},"linkedDiseases":{"rows":["EFO_1000783","EFO_0006510"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545206","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK1482160","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK1482160","Gsk1482160"],"count":1,"linkedTargets":{"rows":["ENSG00000089041"],"count":1},"linkedDiseases":{"rows":["EFO_0003843"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545241","canonicalSmiles":"Cc1cc(Nc2nc(C(O)c3ccc(F)cc3)nc3ccccc23)n[nH]1","inchiKey":"DCRWIATZWHLIPN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AC-430","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AC430","Ac-430"],"crossReferences":{"drugbank":["DB12535"]},"count":1,"linkedTargets":{"rows":["ENSG00000096968"],"count":1},"linkedDiseases":{"rows":["EFO_0000685"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545985","canonicalSmiles":"C[C@@H](Cc1ccccc1)N(C)Cc1ccccc1","inchiKey":"YXKTVDFXDRQTKV-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZPHETAMINE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Benzfetamine"],"crossReferences":{"DailyMed":["benzphetamine%20hydrochloride"],"drugbank":["DB00865"],"chEBI":["3044"]},"childChemblIds":["CHEMBL3544906"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1960."}
{"id":"CHEMBL3586573","canonicalSmiles":"CCN1C(=O)CNc2ncc(-c3ccc(-c4nc[nH]n4)nc3C)nc21","inchiKey":"GMYLVKUGJMYTFB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3586573","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB12740"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL366312","canonicalSmiles":"OCCNc1ncnc2[nH]c(-c3ccccc3)c(-c3ccccc3)c12","inchiKey":"MPJYGQHMIFDQIN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL366312","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07655"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707212","canonicalSmiles":"CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C","inchiKey":"GTFUITFQDGVJSK-XGXHKTLJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GESTONORONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gestonorone"],"crossReferences":{"drugbank":["DB13230"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3707229","drugType":"Antibody","blackBoxWarning":false,"name":"TEZEPELUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG 157","MEDI19929","Tezepelumab"],"count":4,"linkedTargets":{"rows":["ENSG00000145777"],"count":1},"linkedDiseases":{"rows":["EFO_0000270","EFO_0000341","EFO_0000274","EFO_0003785"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3707301","canonicalSmiles":"COc1ccc(C2(c3ccc(OC)cc3)NC(=O)N(CCN3CCCCC3)C2=O)cc1","inchiKey":"HVYGXNYMNHSBGD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IDANPRAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Idanpramine"],"crossReferences":{"drugbank":["DB13276"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3707325","drugType":"Antibody","blackBoxWarning":false,"name":"LENZILUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KB-003","KB003","Lenzilumab"],"count":5,"linkedTargets":{"rows":["ENSG00000164400"],"count":1},"linkedDiseases":{"rows":["EFO_0003106","EFO_0000685","EFO_1001779","MONDO_0100096","EFO_0000096","EFO_0000270"],"count":6},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL3833314","canonicalSmiles":"Cl[Al](Cl)Cl.O.O.O.O.O.O","inchiKey":"JGDITNMASUZKPW-UHFFFAOYSA-K","drugType":"Small molecule","blackBoxWarning":false,"name":"ALUMINUM CHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL3833401","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Anhydrol fte","Driclor","Gppe a-pers","Odaban"],"synonyms":["Aluminium chloride","Aluminum chloride"],"crossReferences":{"DrugCentral":["4436"]},"count":1,"approvedIndications":["EFO_0003894"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for acne."}
{"id":"CHEMBL388751","canonicalSmiles":"OCC(O)COc1ccc(Cl)cc1","inchiKey":"MXOAEAUPQDYUQM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL388751","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144207103"],"drugbank":["DB00856"],"chEBI":["3642"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3913031","canonicalSmiles":"C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1.O=C(O)CC(O)(CC(=O)O)C(=O)O","inchiKey":"XXHUVQHLUMNMCZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3913031","maximumClinicalTrialPhase":0,"parentId":"CHEMBL598797","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3962672","canonicalSmiles":"CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O.Cl","inchiKey":"STEQOHNDWONVIF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3962672","maximumClinicalTrialPhase":0,"parentId":"CHEMBL189963","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3990043","drugType":"Gene","blackBoxWarning":false,"name":"DONAPERMINOGENE SELTOPLASMID","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Donaperminogene seltoplasmid","VM202"],"count":6,"description":"Gene drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL4","canonicalSmiles":"CC1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23","inchiKey":"GSDSWSVVBLHKDQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"OFLOXACIN","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Exocin","Floxin","Floxin otic","Ocuflox","Ofloxacin","Tarivid","Tarivid 400","Tarivid i.v.","Visiren"],"synonyms":["DL-8280","HOE 280","HOE-280","J01MA01","Ofloxacin"],"crossReferences":{"DailyMed":["ofloxacin"],"PubChem":["11533038","124880995","124880996","144204254","170465035","174006255","174007433","26747609","26747610","50106760","56423109","85231170","90341488"],"Wikipedia":["Ofloxacin"],"drugbank":["DB01165"],"chEBI":["7731"]},"childChemblIds":["CHEMBL556371"],"count":13,"approvedIndications":["EFO_0000771","EFO_0000544","EFO_1001888"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1990 and has 3 approved and 10 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL415324","canonicalSmiles":"COc1ccc(/C=C/C(=O)Nc2ccccc2C(=O)O)cc1OC","inchiKey":"NZHGWWWHIYHZNX-CSKARUKUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRANILAST","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-341","Tranilast"],"crossReferences":{"PubChem":["144204387","26719641","49645767","50103918","50103919","50103920","56422140","85231347","855567","90341124"],"Wikipedia":["Tranilast"],"drugbank":["DB07615"],"chEBI":["77572"]},"count":4,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4208229","canonicalSmiles":"O=C(Nc1ccc(OC(F)(F)Cl)cc1)c1cnc(N2CC[C@@H](O)C2)c(-c2cc[nH]n2)c1","inchiKey":"VOVZXURTCKPRDQ-CQSZACIVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ASCIMINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABL-001","ABL001","ABL001-NX","Abl-001","Asciminib","NVP-ABL001"],"crossReferences":{"drugbank":["DB12597"]},"childChemblIds":["CHEMBL4297220"],"count":4,"linkedTargets":{"rows":["ENSG00000097007"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003086","EFO_0000339","EFO_0000220"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL420937","canonicalSmiles":"C[C@@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23","inchiKey":"GSDSWSVVBLHKDQ-SNVBAGLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXTROFLOXACINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11111577","11112864"],"drugbank":["DB03034"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297240","drugType":"Gene","blackBoxWarning":false,"name":"ONASEMNOGENE ABEPARVOVEC","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AVXS-101","Onasemnogene abeparvovec"],"count":1,"linkedTargets":{"rows":["ENSG00000172062","ENSG00000205571"],"count":2},"linkedDiseases":{"rows":["EFO_0008525","Orphanet_139525","Orphanet_139547","Orphanet_1145","Orphanet_83419","Orphanet_404521","Orphanet_139518","Orphanet_98920","Orphanet_83418","Orphanet_83330","Orphanet_139552"],"count":11},"description":"Gene drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297505","canonicalSmiles":"CCc1cc(-c2noc(-c3cc(OC)nc(C4CCCC4)c3)n2)cc(C)c1OC[C@@H](O)CO","inchiKey":"KJKKMMMRWISKRF-FQEVSTJZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CENERIMOD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ACT-334441","ACT334441","Act-334441","Cenerimod"],"crossReferences":{"drugbank":["DB12705"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297560","drugType":"Antibody","blackBoxWarning":false,"name":"GATIPOTUZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gatipotuzumab"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297581","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"TOMINERSEN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ionis httrx","Isis 443139","RG6042","Rg6042","Ro7234292","Tominersen"],"count":1,"linkedTargets":{"rows":["ENSG00000197386"],"count":1},"linkedDiseases":{"rows":["Orphanet_399"],"count":1},"description":"Oligonucleotide drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297608","canonicalSmiles":"C=C1/C(=C\\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)(C)O)C[C@@H](O)[C@@H](OCCCO)[C@@H]1O","inchiKey":"FZEXGDDBXLBRTD-AYIMTCTASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELDECALCITOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ed-71","Eldecalcitol"],"crossReferences":{"drugbank":["DB05295"]},"count":1,"linkedTargets":{"rows":["ENSG00000111424"],"count":1},"linkedDiseases":{"rows":["EFO_0003882"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297616","canonicalSmiles":"NC(=O)[C@](O)(CNc1nc(-c2cc(-c3ccon3)n(Cc3ccccc3F)n2)ncc1F)C(F)(F)F","inchiKey":"YWQFJNWMWZMXRW-HXUWFJFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLINCIGUAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IW-1701","IW1701","Iw-1701","Olinciguat"],"crossReferences":{"drugbank":["DB15238"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297690","drugType":"Protein","blackBoxWarning":false,"name":"NOGAPENDEKIN ALFA","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ALT-803","Alt-803","IL-15N72D","N-803","Nogapendekin alfa"],"count":21,"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 21 investigational indications."}
{"id":"CHEMBL4297766","drugType":"Unknown","blackBoxWarning":false,"name":"HYDROGEN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hydrogen"],"count":4,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297883","drugType":"Antibody","blackBoxWarning":false,"name":"IVUXOLIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anti-ox40 antibody pf-04518600","Ivuxolimab","PF-04518600","PF-8600","PF04518600","Pf-04518600","Pf04518600"],"count":7,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL4297919","drugType":"Unknown","blackBoxWarning":false,"name":"PAROXETINE HYDROCHLORIDE HEMIHYDRATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BRL29060A","Brl29060a","Paroxetine hydrochloride","Paroxetine hydrochloride hemihydrate","Paroxetine hydrochloride hydrate"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297938","drugType":"Antibody","blackBoxWarning":false,"name":"LIFASTUZUMAB VEDOTIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DNIB-0600A","DNIB0600A","Dnib0600a","Lifastuzumab vedotin","NAPI3B","RG-7599"],"count":2,"linkedTargets":{"rows":["ENSG00000261456","ENSG00000188229","ENSG00000104833","ENSG00000137267","ENSG00000157765","ENSG00000258947","ENSG00000101162","ENSG00000137285","ENSG00000196230","ENSG00000176014"],"count":10},"linkedDiseases":{"rows":["MONDO_0008170","EFO_0003060"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4298018","drugType":"Unknown","blackBoxWarning":false,"name":"LY-3164530","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-3164530","LY3164530","Ly 3164530","Ly-3164530","Ly3164530"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4298027","drugType":"Unknown","blackBoxWarning":false,"name":"PRX-321","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MDNA55","Mdna55","NBI-3001","PRX-321","PRX321","Prx-321"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4298029","drugType":"Unknown","blackBoxWarning":false,"name":"MEDI-0639","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MEDI-0639","MEDI0639","Medi 0639","Medi-0639","Medi0639"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4298187","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"FERRIC DERISOMALTOSE","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Diafertm","Monofartm","Monoferric","Monoferrictm","Monoferrotm","Monofertm","Monovertm"],"synonyms":["Ferric derisomaltose","NS32"],"crossReferences":{"DailyMed":["ferric%20derisomaltose"]},"count":2,"approvedIndications":["HP_0001891"],"description":"Oligosaccharide drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and is indicated for iron deficiency anemia and has 1 investigational indication."}
{"id":"CHEMBL4298200","drugType":"Cell","blackBoxWarning":false,"name":"LIFILEUCEL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Autologous tumor infiltrating lymphocytes","LN-144","Lifileucel"],"count":1,"description":"Cell drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL430341","canonicalSmiles":"C=C1C[C@@]23CC[C@H]4[C@@](C)(CCC[C@@]4(C)C(=O)O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H]2CC[C@]1(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H]1O)C3","inchiKey":"GIPHUOWOTCAJSR-NCGAPWICSA-N","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"REBAUDIOSIDE A","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E-960A","FEMA NO. 4601","INS NO.960A","INS-960A","Rebaudioside a"],"count":1,"description":"Oligosaccharide drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4468983","canonicalSmiles":"[2H]C([2H])([2H])N(C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1)C([2H])([2H])[2H]","inchiKey":"RHXHGRAEPCAFML-WFGJKAKNSA-N","drugType":"unknown","blackBoxWarning":false,"name":"CHEMBL4468983","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3545110","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Unknown drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL450940","canonicalSmiles":"C=Cc1cc(O)cc2nc(-c3ccc(O)c(F)c3)oc12","inchiKey":"MQIMZDXIAHJKQP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRINABEREL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ERB-041","PF-00913086","Prinaberel"],"crossReferences":{"drugbank":["DB06832"]},"count":3,"linkedTargets":{"rows":["ENSG00000140009"],"count":1},"linkedDiseases":{"rows":["EFO_0001065","HP_0001657","EFO_0000384"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4516632","canonicalSmiles":"O=C(NC1CCNCC1)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(=O)(=O)[O-].[Na+]","inchiKey":"MMUZXOWPDRLGBD-UXQCFNEQSA-M","drugType":"unknown","blackBoxWarning":false,"name":"CHEMBL4516632","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3112741","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Unknown drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL454","canonicalSmiles":"C=CCC1(CC(C)C)C(=O)NC(=O)NC1=O","inchiKey":"UZVHFVZFNXBMQJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTALBITAL","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sandoptal"],"synonyms":["Alisobumal","Allylbarbituric acid","Butalbital","Butalbital ciii","Itobarbital","Tetrallobarbital"],"crossReferences":{"DailyMed":["butalbital"],"Wikipedia":["Butalbital"],"drugbank":["DB00241"],"chEBI":["102524"]},"count":1,"approvedIndications":["EFO_0003821"],"linkedTargets":{"rows":["ENSG00000145864","ENSG00000166206","ENSG00000163288"],"count":3},"linkedDiseases":{"rows":["EFO_0003821"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1983 and is indicated for migraine disorder."}
{"id":"CHEMBL45412","canonicalSmiles":"O=C(O)CC(=O)N[C@@H](CS)Cc1ccccc1","inchiKey":"REPVVNYZORKKPQ-SNVBAGLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL45412","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01935"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL455461","canonicalSmiles":"CC(=O)NC[C@H]1CN(c2ccc(-c3ccc(CNCc4cnn[nH]4)cc3)c(F)c2)C(=O)O1","inchiKey":"BTTNOGHPGJANSW-IBGZPJMESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RADEZOLID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RX-013","RX-01_667","RX-103","RX-1741","RX-O1_667","Radezolid"],"crossReferences":{"Wikipedia":["Radezolid"],"drugbank":["DB12339"]},"childChemblIds":["CHEMBL2105651"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL456341","canonicalSmiles":"CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC=C(C(=O)O)C[C@@H]21","inchiKey":"YCHYFHOSGQABSW-RTBURBONSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LENABASUM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ajulemic Acid","Ajulemic acid","CPL-7075","CPL7075","CT-3","HU-239","IP-751","JBT-101","Lenabasum"],"crossReferences":{"Wikipedia":["Ajulemic_acid"],"drugbank":["DB12193"]},"count":4,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4594252","canonicalSmiles":"O=[Al]O[Al]=O","inchiKey":"TWNQGVIAIRXVLR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALUMINIUM OXIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alum ox","Brasivol 1","Brasivol 2","Brasivol 3"],"synonyms":["Aluminium oxide"],"count":1,"approvedIndications":["EFO_0003894"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for acne."}
{"id":"CHEMBL4594290","canonicalSmiles":"NCCNC1CCC(CC(=O)N[C@H]2Cc3cccc(C(=O)O)c3OB2O)CC1","inchiKey":"PFZUWUXKQPRWAL-PXCJXSSVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TANIBORBACTAM","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Taniborbactam","VNRX-5133","Vnrx-5133"],"childChemblIds":["CHEMBL4594291"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594353","canonicalSmiles":"Cc1nc2ccc(F)cc2n1-c1nc(N)c(F)c(Nc2ccc(C(F)(F)F)cc2)n1","inchiKey":"TWLWOOPCEXYVBE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PTC-596","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PTC 596","PTC596","Ptc-596","Ptc596"],"count":4,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4594360","drugType":"Unknown","blackBoxWarning":false,"name":"TRK-950","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TRK-950","Trk-950"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594474","drugType":"Unknown","blackBoxWarning":false,"name":"FN-1501","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FN-1501","Fn-1501"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594490","drugType":"Unknown","blackBoxWarning":false,"name":"RECAP","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Recap"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594605","drugType":"Unknown","blackBoxWarning":false,"name":"OMFILOCTOCOG ALFA","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Omfiloctocog alfa","SCT-800","SCT800","Sct800"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4594616","drugType":"Unknown","blackBoxWarning":false,"name":"BISMUTH TRIBROMOPHENATE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bismuth tribromophenate","Xeroform"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL463588","canonicalSmiles":"CC(C)(CCl)C(=O)Nc1ccc(C(F)(F)F)cc1","inchiKey":"QCQZFHOGRCQNIH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL463588","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["24817013"],"drugbank":["DB07805"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL467399","canonicalSmiles":"COc1c(C)cnc(Cn2cnc3c(Cl)nc(N)nc32)c1C","inchiKey":"QULDDKSCVCJTPV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIIB021","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIIB 021","BIIB-021","Biib021","CNF2024","Cnf2024"],"crossReferences":{"PubChem":["124954167"],"drugbank":["DB12359"],"chEBI":["90687"]},"childChemblIds":["CHEMBL3526911","CHEMBL557165"],"count":5,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL477486","canonicalSmiles":"Nc1nc2c(ncn2[C@H]2C[C@H](O)[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]1","inchiKey":"HAAZLUGHYHWQIW-KVQBGUIXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEOXYGUANOSINE TRIPHOSPHATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["deoxyguanosine triphosphate"],"crossReferences":{"Wikipedia":["Deoxyguanosine_triphosphate"],"drugbank":["DB02181"],"chEBI":["16497"]},"childChemblIds":["CHEMBL2368456"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL479579","canonicalSmiles":"CC(C)C[C@H](NP(=O)(O)O[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O","inchiKey":"ZPHBZEQOLSRPAK-XLCYBJAPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHOSPHORAMIDON","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Phosphoramidon","Phosphramidon","Phosporamidon"],"crossReferences":{"Wikipedia":["Phosphoramidon"],"drugbank":["DB02557"],"chEBI":["45353"]},"childChemblIds":["CHEMBL2028192"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL499458","canonicalSmiles":"CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1","inchiKey":"OGWKCGZFUXNPDA-CFWMRBGOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL499458","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["164339426"],"drugbank":["DB00541"]},"childChemblIds":["CHEMBL385978"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL501351","canonicalSmiles":"C=C1CCC2CC1C2(C)C","inchiKey":"WTARULDDTDQWMU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BETA-PINENE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Beta-Pinene"],"crossReferences":{"PubChem":["144207227"],"Wikipedia":["Beta-Pinene"],"drugbank":["DB15574"],"chEBI":["50025"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL511142","canonicalSmiles":"CO[C@@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1Cc4ccc(O)c5c4[C@@]3(CCN1CC1CC1)[C@H]2O5","inchiKey":"RMRJXGBAOAMLHD-CTAPUXPBSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BUPRENORPHINE","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bupeaze","Buplast","Butec","Butrans","Hapoctasin","Panitaz","Prenotrix","Reletrans","Sevodyne","Sublocade","Temgesic","Tephine","Transtec"],"synonyms":["ALKS-5461 COMPONENT BUPRENORPHINE","Buprenorphine"],"crossReferences":{"DailyMed":["buprenorphine","buprenorphine%20hydrochloride"]},"childChemblIds":["CHEMBL2368861"],"count":23,"approvedIndications":["EFO_0003890","MONDO_0002491","HP_0012532","EFO_0003843"],"linkedTargets":{"rows":["ENSG00000082556","ENSG00000112038"],"count":2},"linkedDiseases":{"rows":["EFO_0004240","EFO_0002610","MONDO_0002009","Orphanet_232","MONDO_0002050","EFO_0002506","HP_0003419","EFO_0003047","HP_0008419","EFO_0005799","EFO_1001250","EFO_0005762","HP_0012532","EFO_0005612","EFO_0010072","EFO_0001358","HP_0003418","EFO_0010702","EFO_0003843","EFO_0000311","EFO_1001412","EFO_0004220","EFO_0003890","MONDO_0002491","EFO_0005800","EFO_0000764","EFO_0005611","EFO_0004270"],"count":28},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and has 4 approved and 19 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL512283","canonicalSmiles":"C[C@](O)(COc1ccc(Cl)c(F)c1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1","inchiKey":"SSFVOEAXHZGTRJ-KRWDZBQOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL512283","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07419"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL529437","canonicalSmiles":"COC(=O)[C@H]1[C@@H](OC(=O)c2ccccc2)C[C@@H]2CC[C@H]1N2C.Cl","inchiKey":"PIQVDUKEQYOJNR-VZXSFKIWSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"COCAINE HYDROCHLORIDE","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL370805","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Goprelto","Numbrino"],"synonyms":["Cocaine hydrochloride","Cocaine hydrochloride cii","MCV 4526","NIH 8211","NSC-25263","RX-0041-002"],"crossReferences":{"DailyMed":["cocaine%20hydrochloride"],"PubChem":["144206436"],"chEBI":["613010"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2017 and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL535","canonicalSmiles":"CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\\C(=O)Nc3ccc(F)cc32)c1C","inchiKey":"WINHZLLDWRZWRT-ATVHPVEESA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"SUNITINIB","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sutent"],"synonyms":["SU-011248","SU-11248","SU011248","Sunitinib","Sutent"],"crossReferences":{"DailyMed":["sunitinib%20malate"],"PubChem":["124893176","26758053","50100120"],"Wikipedia":["Sunitinib"],"drugbank":["DB01268"],"chEBI":["38940"]},"childChemblIds":["CHEMBL3109278","CHEMBL3542310","CHEMBL1567"],"count":56,"approvedIndications":["EFO_0000616","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000134853","ENSG00000128052","ENSG00000165731","ENSG00000102755","ENSG00000037280","ENSG00000113721","ENSG00000157404","ENSG00000182578","ENSG00000122025"],"count":9},"linkedDiseases":{"rows":["EFO_0003869","EFO_1000403","EFO_0000637","EFO_0000558","EFO_0000756","EFO_0000681","EFO_0000228","EFO_1000984","EFO_0000632","EFO_1001951","EFO_0000588","MONDO_0003268","MONDO_0008903","EFO_0000182","EFO_1000251","EFO_0008528","EFO_0000501","EFO_0000641","MONDO_0015277","EFO_0000514","EFO_0007243","EFO_1000045","EFO_0002618","EFO_0000220","MONDO_0008170","EFO_0000349","EFO_1001968","MONDO_0008315","EFO_0005221","EFO_0007143","EFO_0000294","MONDO_0002691","EFO_1000576","Orphanet_398934","MONDO_0044787","EFO_0001378","EFO_1000796","MONDO_0021640","EFO_0000292","EFO_0002938","MONDO_0004192","EFO_0007416","EFO_1001901","EFO_1001465","MONDO_0007254","EFO_0004252","MONDO_0002087","EFO_0000350","MONDO_0020654","MONDO_0001187","Orphanet_892","MONDO_0001056","EFO_1001480","EFO_1000044","MONDO_0002158","EFO_0006352","EFO_1001974","EFO_0000673","EFO_0000196","EFO_0002499","EFO_0000239","EFO_1000042","EFO_0002617","HP_0001541","EFO_0000616","EFO_0003897","EFO_1000616","EFO_0007331","Orphanet_44890","EFO_0000403","EFO_0000222","MONDO_0007576","EFO_0000313","EFO_0004243","EFO_0003060","MONDO_0003865","EFO_0000311","EFO_0000640","EFO_0003863","EFO_0003865","EFO_1000581","EFO_0006861","EFO_0000095","EFO_0002892","EFO_0004142","EFO_0000702","MONDO_0002367","MONDO_0024880","EFO_0000691","EFO_0000519","EFO_0000181","MONDO_0044926"],"count":92},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and is indicated for cancer and neoplasm and has 54 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL537674","canonicalSmiles":"CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C.Cl","inchiKey":"REPUEGIPTSPLQL-PBCQUBLHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL537674","maximumClinicalTrialPhase":0,"parentId":"CHEMBL94","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL561318","canonicalSmiles":"O=C(CN1C[C@H](O)[C@@H](NC(=O)c2ccc(Cl)s2)C1)Nc1ccc(-n2ccccc2=O)cc1F","inchiKey":"ARAVOODWJJJNBY-IRXDYDNUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL561318","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07875"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL569","canonicalSmiles":"CCN(CC)CCOC(=O)c1ccc(N)cc1","inchiKey":"MFDFERRIHVXMIY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROCAINE","yearOfFirstApproval":1954,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["NSC-169497","Novocain","Procaine"],"crossReferences":{"PubChem":["11111696","11111697","90341175"],"Wikipedia":["Procaine"],"drugbank":["DB00721"],"chEBI":["8430"]},"childChemblIds":["CHEMBL1200841"],"count":2,"approvedIndications":["EFO_0009552"],"linkedTargets":{"rows":["ENSG00000185313","ENSG00000153253","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000007314","ENSG00000136531","ENSG00000196876"],"count":10},"linkedDiseases":{"rows":["EFO_0000764","EFO_0009552","EFO_0003102"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1954 and is indicated for hemorrhoid and has 1 investigational indication."}
{"id":"CHEMBL575218","canonicalSmiles":"COc1cc(-c2ccc(C)cc2)cc([C@@H](C)C#Cc2c(C)nc(N)nc2N)c1","inchiKey":"QVXYJVHNRPNRJL-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL575218","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07141"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL591118","canonicalSmiles":"COc1cc2c(cc1OC)[C@@H]1C[C@H](N)[C@@H](N3C[C@@H](CF)CC3=O)CN1CC2","inchiKey":"GUYMHFIHHOEFOA-ZCPGHIKRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARMEGLIPTIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Carmegliptin","R-1579","R1579","RO-4876904","RO4876904"],"crossReferences":{"drugbank":["DB12268"]},"childChemblIds":["CHEMBL2105633"],"count":1,"linkedTargets":{"rows":["ENSG00000197635"],"count":1},"linkedDiseases":{"rows":["EFO_0001360"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL592878","canonicalSmiles":"CC(=O)N[C@]1(C(N)=O)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O","inchiKey":"BUPVODXECQDZQR-YCOWOFQRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL592878","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04544"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL593791","canonicalSmiles":"CN1C(=O)N[C@@]2(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C1=O","inchiKey":"RIUIMUSXAGXXON-FMTWGGRWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL593791","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03479"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL604710","canonicalSmiles":"O=C(CC(c1ccccc1)c1ccccc1)N1CCN(C(c2ccccc2)c2ccccc2)CC1","inchiKey":"VCPMZDWBEWTGNW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Z160","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-6721","MK6721","NMED-160","NP-118809","Z160"],"crossReferences":{"drugbank":["DB12743"]},"count":1,"linkedTargets":{"rows":["ENSG00000148408"],"count":1},"linkedDiseases":{"rows":["MONDO_0002959","EFO_0006510"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL63055","canonicalSmiles":"O=C(O)CN1C(=O)c2cccc3cccc(c23)C1=O","inchiKey":"GCUCIFQCGJIRNT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALRESTATIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AY-22284","Alrestatin"],"crossReferences":{"PubChem":["11113527","170466470","26751737"],"drugbank":["DB02020"]},"childChemblIds":["CHEMBL2106598"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL633","canonicalSmiles":"CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1","inchiKey":"IYIKLHRQXLHMJQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"AMIODARONE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cordarone"],"synonyms":["Amiodarone","Cordarone","L-3428","Pacerone","SKF 33134-A"],"crossReferences":{"DailyMed":["amiodarone%20hydrochloride"],"PubChem":["104171110","11110784","11110785","124879287","144203634","170464920","26751596","26751597","50100172","90341282"],"TG-GATEs":["33"],"Wikipedia":["Amiodarone"],"drugbank":["DB01118"],"chEBI":["2663"]},"childChemblIds":["CHEMBL1083993"],"count":15,"approvedIndications":["EFO_0004269","HP_0004308"],"linkedTargets":{"rows":["ENSG00000055118"],"count":1},"linkedDiseases":{"rows":["EFO_0000275","EFO_0004269","EFO_0000318","EFO_0005529","EFO_0004278","EFO_0001645","EFO_0000373","Orphanet_85443","EFO_0003911","MONDO_0100096","EFO_0004287","HP_0004755","EFO_0005306","EFO_0003144","HP_0004308","EFO_0000612","EFO_0007243","EFO_0009492"],"count":18},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and is indicated for cardiac arrhythmia and ventricular arrhythmia and has 13 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL700","canonicalSmiles":"Nc1ccc(S(=O)(=O)Nc2ccccn2)cc1","inchiKey":"GECHUMIMRBOMGK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFAPYRIDINE","yearOfFirstApproval":1939,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Coccoclase","Concord 693","Dagenan","Eubasin","Piridazol","Sulfanilamidopyridine","Sulfapyridine"],"synonyms":["Sulfapyridine","Sulphapyridine"],"crossReferences":{"PubChem":["11112302","144203977","170464707","26746948","855656"],"Wikipedia":["Sulfapyridine"],"drugbank":["DB00891"],"chEBI":["132842"]},"childChemblIds":["CHEMBL2105500"],"count":1,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1939 and is indicated for bacterial disease."}
{"id":"CHEMBL757","canonicalSmiles":"C[C@]12CC[C@@H]3[C@H]4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@H]2O","inchiKey":"NPAGDVCDWIYMMC-IZPLOLCNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NANDROLONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Deca-Durabolin","Durabolin","NSC-3351","Nandrolone","Nandrolone ciii"],"crossReferences":{"PubChem":["144206718","144206750","144208410","170466348","29215354","85148374"],"Wikipedia":["Nandrolone"],"drugbank":["DB13169"],"chEBI":["7466"]},"childChemblIds":["CHEMBL3337497"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL816","canonicalSmiles":"NCCN","inchiKey":"PIICEJLVQHRZGT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHYLENEDIAMINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Edamine","Ethylenediamine"],"crossReferences":{"PubChem":["144204696","144208400","17389605"],"Wikipedia":["Ethylenediamine"],"drugbank":["DB14189"],"chEBI":["30347"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL86","canonicalSmiles":"CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC","inchiKey":"TTWJBBZEZQICBI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"METOCLOPRAMIDE","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Clopra","Clopra-\"Yellow\"","Maxolon","Metoclopramide","Reglan"],"crossReferences":{"DailyMed":["metoclopramide%20hydrochloride"],"PubChem":["11111421","11111422","144203739","170464848","26751627","90341551"],"Wikipedia":["Metoclopramide"],"drugbank":["DB01233"],"chEBI":["107736"]},"childChemblIds":["CHEMBL1200940","CHEMBL1256771"],"count":20,"approvedIndications":["EFO_0010282"],"linkedTargets":{"rows":["ENSG00000149295","ENSG00000164270","ENSG00000166736"],"count":3},"linkedDiseases":{"rows":["HP_0002239","HP_0002321","EFO_0005252","EFO_1000948","MONDO_0004565","HP_0002018","EFO_0002950","EFO_0003913","EFO_0003948","EFO_1000645","HP_0002017","EFO_0005295","HP_0002013","EFO_0003917","EFO_0000198","EFO_0000616","EFO_0005296","EFO_0006911","EFO_0003821","EFO_1000949","EFO_0003843","MONDO_0008315","HP_0002315","EFO_1000971","HP_0100806","EFO_0000546","EFO_1001463","EFO_0010282","Orphanet_230","EFO_0000764","EFO_0004888","EFO_0008583","EFO_0000612","EFO_0005611","HP_0001943"],"count":35},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1979 and is indicated for gastrointestinal disease and has 19 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL89363","canonicalSmiles":"Cc1c[nH]c(/C=C2\\C(=O)Nc3ccccc32)c1CCC(=O)O","inchiKey":"JNDVEAXZWJIOKB-JYRVWZFOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SU-5402","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SU-5402"],"crossReferences":{"drugbank":["DB08577"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL94394","canonicalSmiles":"CCCCOc1ccc(CC(=O)NO)cc1","inchiKey":"MXJWRABVEGLYDG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUFEXAMAC","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Anderm","Duradermal","Paraderm","Parfenac"],"synonyms":["Bufexamac","Butoxyphenylacethydroxamic acid","CP 1044 J3"],"crossReferences":{"PubChem":["11112517","124882428","124882430","144204073","170465813","26746938","56422414","855633"],"drugbank":["DB13346"],"chEBI":["31317"]},"count":3,"approvedIndications":["HP_0002829","HP_0003326","EFO_0005755"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 3 approved indications."}
